rfhg_134873.1

Basic information about the TSS

---

TSS ID: rfhg_134873.1 Species: human Chr: chr11		Start: 18322254 End: 18322322 Strand: +
Source datasets	PRJNA4843412|DRA013844
Protocol	NETCAGE|CAGE
TSS cluster detected*	2

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2429083,EH38E1525166)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000453096.6:0 AK027003:0 GeneID: 2965 HGNC/MGI_ID: HGNC:4655 UniProt_ID: A0A384MTQ8 Nearer transcript ids and distances: ENST00000531757.5:225 ENST00000418116.6:235 ENST00000534213.5:245 ENST00000534641.5:245 ENST00000265963.9:245 NM_005316.4:245 NM_001142307.2:245 AK299621:245 AK127204:245 ENST00000526461.1:246 ENST00000525831.5:247 AK299730:247 ENST00000532227.1:260 BC000365:274 BC004452:274 GQ891448:274 AK312974:285 M95809:380 view more...

Gene_name: general transcription factor IIH subunit 1 Gene_symbol: GTF2H1 Gene_synonyms: BTF2 P62 TFIIH Gene_source: HGNC:4655

TATA-Box annotation

---

Distance to TSS:	19
Nearest PromoterID:	NM_001142307
Entrez ID:	2965
Nearest Unigene:	Hs.577202
Nearest Refseq:	NM_005316
Nearest Ensembl:	ENSG00000110768
Gene Name:	general transcription factor IIH subunit 1
Gene Alias:	BTF2|P62|TFB1|TFIIH
Gene Type:	protein-coding
CpG%:	0.132353
GC%:	0.681159
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@GTF2H1 p2@GTF2H1 p3@GTF2H1 p4@GTF2H1
Sample		p1@GTF2H1	p2@GTF2H1	p3@GTF2H1	p4@GTF2H1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	30.00	3.31	15.58	6.23
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	32.57	4.05	12.54	5.46
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	28.55	3.67	15.05	5.59
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	32.64	3.12	9.77	6.24
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	27.00	4.50	11.47	3.60
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	26.36	3.29	9.50	5.23
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	37.69	5.66	12.64	4.58
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	31.73	3.88	8.24	5.81
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	35.90	4.27	10.69	4.27
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	35.36	4.64	22.61	24.34
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	32.34	4.04	21.02	18.19
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	30.90	2.44	26.02	16.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	13.70	3.22	4.67	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	11.13	4.66	3.91	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	10.98	1.76	4.39	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	10.31	3.52	6.54	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	9.61	4.15	4.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	9.70	2.53	5.48	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	12.26	3.73	2.13	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	11.58	1.81	5.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	13.90	2.54	4.81	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	15.71	2.59	5.70	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	15.12	2.84	5.69	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	11.65	3.40	4.37	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	9.03	5.16	5.16	1.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	8.55	3.80	5.70	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	14.84	4.95	2.20	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	15.32	2.36	5.42	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	10.34	3.55	6.46	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	10.13	2.90	4.34	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	11.30	3.77	4.61	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	15.83	2.93	3.71	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	11.61	2.74	4.64	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	17.48	4.95	5.77	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	11.59	4.11	4.11	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	12.26	2.11	4.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	12.26	3.68	4.29	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	12.49	2.62	5.24	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	15.67	5.40	4.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	10.32	4.80	5.76	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	11.76	4.00	2.59	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	16.54	2.78	2.78	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	12.23	2.74	2.95	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	12.59	2.45	4.37	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	12.25	4.42	4.22	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	13.03	3.49	4.19	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	13.67	4.56	4.56	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	8.35	4.47	2.38	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	13.64	4.55	4.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	14.96	2.83	5.66	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	14.35	3.48	5.33	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	16.46	6.00	5.34	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	167.91	83.95	0.00	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	15.61	5.68	4.97	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	15.24	4.31	6.30	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	43.62	9.23	10.07	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	22.50	3.67	4.13	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	12.96	4.54	7.45	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	16.06	4.18	4.18	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	22.63	4.40	5.34	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	14.81	4.94	7.05	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	16.26	5.05	5.61	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	24.68	1.59	3.18	1.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	18.69	3.06	3.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	17.87	5.20	2.92	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	16.33	4.97	3.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	80.82	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	118.46	31.59	7.90	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	17.06	3.41	1.46	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	12.40	3.47	4.96	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	16.42	6.10	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	16.56	3.64	0.99	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	14.23	3.40	1.86	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	15.59	3.97	0.92	0.00
Adipocyte - breast, donor1	11376-118A8	39.12	11.72	11.56	4.75
Adipocyte - breast, donor2	11327-117E4	16.36	7.06	11.39	2.09
Adipocyte - omental, donor1	11473-119C6	43.13	11.96	16.16	4.20
Adipocyte - omental, donor2	11474-119C7	17.94	4.48	11.96	2.99
Adipocyte - omental, donor3	11475-119C8	27.46	6.36	5.36	2.01
Adipocyte - perirenal, donor1	11476-119C9	26.16	4.47	10.21	4.47
Adipocyte - subcutaneous, donor1	11259-116F8	12.09	4.40	4.40	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	30.26	6.77	4.06	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	10.25	4.34	2.26	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	33.83	9.39	5.67	1.37
Adipocyte differentiation, day04, donor2	13022-139D7	23.42	7.46	1.80	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	20.91	5.58	6.41	0.84
Adipocyte differentiation, day04, donor4	13028-139E4	18.22	4.11	8.23	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	23.73	7.96	9.41	0.24
Adipocyte differentiation, day08, donor2	13023-139D8	24.21	7.10	5.49	0.97
Adipocyte differentiation, day08, donor3	13026-139E2	16.53	7.46	10.66	1.07
Adipocyte differentiation, day08, donor4	13029-139E5	16.14	6.12	6.68	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	9.98	8.32	11.23	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	18.59	9.04	4.77	0.75
Adipocyte differentiation, day12, donor3	13027-139E3	15.71	6.87	8.84	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	13.09	2.74	5.18	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	7.51	2.65	1.33	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	1.79	0.00	1.79	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	2.40	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	7.02	1.62	1.80	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	5.02	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	5.75	2.47	1.85	0.21
Anulus Pulposus Cell, donor1	11248-116E6	26.09	9.27	7.44	0.23
Anulus Pulposus Cell, donor2	11463-119B5	15.18	4.16	5.88	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	13.93	5.84	2.70	0.90
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	19.10	5.64	3.47	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	8.56	12.84	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	17.04	8.07	3.29	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	17.71	5.06	3.79	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	11.22	3.96	3.96	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	14.94	4.55	3.57	1.30
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	20.39	8.25	1.94	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	19.60	3.56	5.94	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	15.07	4.52	2.64	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	18.87	5.81	4.35	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	11.28	5.02	2.51	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	23.39	7.91	4.12	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	17.74	2.73	5.46	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	15.53	7.39	4.07	0.75
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	19.82	8.57	3.21	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	13.41	4.53	2.46	0.94
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	16.84	4.54	5.08	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	23.41	7.80	4.88	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	17.25	4.81	2.82	0.66
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	16.81	7.20	1.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	7.08	10.62	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	13.21	4.63	4.63	0.51
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	20.97	4.19	8.39	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	19.90	5.34	4.85	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	17.08	5.69	4.93	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	14.54	7.27	6.06	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	11.97	3.99	4.56	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	15.39	5.34	6.20	0.43
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	16.26	5.94	3.61	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	18.77	4.69	5.63	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	14.15	3.86	1.61	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	12.84	3.57	4.99	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	9.94	5.26	5.26	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	19.27	4.82	4.82	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	17.82	8.32	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	14.75	2.54	2.54	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	14.77	5.09	4.08	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	12.07	3.81	3.18	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	12.95	6.47	1.73	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	11.85	5.29	3.60	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	11.31	5.22	3.19	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	17.01	6.61	5.67	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	17.63	3.90	3.56	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	9.27	9.27	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	16.90	14.79	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	10.94	5.15	5.79	1.07
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	15.04	4.81	2.41	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	13.12	1.46	2.92	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	16.78	5.06	4.14	0.69
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	2.55	2.55	2.55	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	17.80	7.88	5.85	0.76
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	16.72	5.78	4.54	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	14.08	6.73	6.12	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	18.16	5.74	5.74	0.96
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	15.97	5.32	3.10	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	13.73	1.53	3.05	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	14.40	4.98	4.43	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	16.42	5.83	2.91	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	10.90	5.45	4.72	0.36
Astrocyte - cerebellum, donor1	11500-119F6	10.07	1.11	2.09	0.49
Astrocyte - cerebellum, donor2	11580-120F5	3.08	1.20	4.11	0.00
Astrocyte - cerebellum, donor3	11661-122F5	3.78	0.42	1.47	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	34.51	2.79	6.97	1.05
Astrocyte - cerebral cortex, donor2	11316-117D2	22.16	4.04	5.82	0.97
Astrocyte - cerebral cortex, donor3	11392-118C6	20.43	4.92	4.62	0.60
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	40.03	16.97	6.77	0.34
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	46.60	16.66	4.26	1.63
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	40.51	18.44	5.35	0.91
Basophils, donor1	12241-129G9	20.92	4.45	6.02	1.05
Basophils, donor2	12242-129H1	21.29	4.33	4.69	0.72
Basophils, donor3	12243-129H2	11.02	4.26	7.79	0.44
Bronchial Epithelial Cell, donor1	11511-119G8	4.31	1.51	1.08	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	1.37	0.46	0.46	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	12.55	5.02	5.02	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	7.07	3.12	2.08	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	19.80	2.30	4.61	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	15.12	3.96	3.24	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	48.44	14.74	10.41	1.85
Burkitt's lymphoma cell line:RAJI	10476-106I8	71.73	15.37	10.01	0.93
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	35.50	6.40	15.99	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	41.37	20.68	31.03	0.00
CD14+ Monocytes, donor1	11224-116B9	9.02	4.51	8.45	1.13
CD14+ Monocytes, donor2	11305-117B9	10.02	2.60	9.09	1.67
CD14+ Monocytes, donor3	11381-118B4	12.95	4.83	12.07	0.88
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	56.33	17.83	14.44	0.57
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	40.18	14.03	6.82	0.76
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	59.17	17.09	17.42	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	32.67	13.88	13.73	1.59
CD14+ monocytes - mock treated, donor2	11873-125C1	42.24	12.07	9.05	3.92
CD14+ monocytes - mock treated, donor3	11883-125D2	39.56	11.13	14.21	3.32
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	30.80	5.86	12.72	5.19
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	35.05	10.76	8.00	10.49
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	52.81	8.18	16.61	22.56
CD14+ monocytes - treated with BCG, donor1	11860-125A6	23.69	6.07	9.59	3.33
CD14+ monocytes - treated with BCG, donor2	11870-125B7	25.64	11.40	9.26	3.74
CD14+ monocytes - treated with BCG, donor3	11880-125C8	55.71	14.15	14.15	10.88
CD14+ monocytes - treated with Candida, donor1	11868-125B5	27.16	7.49	11.00	6.79
CD14+ monocytes - treated with Candida, donor2	11878-125C6	67.06	8.45	18.48	32.74
CD14+ monocytes - treated with Candida, donor3	11888-125D7	49.92	7.77	23.30	35.50
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	32.43	11.90	11.45	3.87
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	41.71	10.18	11.97	5.19
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	68.08	11.45	18.53	11.24
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	30.20	8.01	10.52	4.80
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	41.17	11.99	8.37	7.01
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	25.75	5.24	9.60	9.17
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	23.67	8.07	9.15	0.81
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	29.13	13.96	9.77	1.92
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	29.88	8.42	11.36	2.10
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	19.47	6.06	7.72	1.65
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	27.12	6.69	4.58	4.23
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	32.03	9.65	10.97	5.70
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	30.52	6.97	9.59	6.45
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	31.96	10.04	8.92	4.83
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	70.05	12.72	13.58	19.83
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	24.16	5.32	8.19	3.69
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	35.70	6.72	9.27	6.95
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	43.85	13.46	10.67	6.96
CD14+CD16+ Monocytes, donor1	11789-124B7	24.41	6.54	6.54	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	23.56	6.24	12.24	0.92
CD14+CD16+ Monocytes, donor3	11912-125G4	24.26	5.85	7.15	0.43
CD14+CD16- Monocytes, donor1	11788-124B6	24.45	8.56	8.56	0.78
CD14+CD16- Monocytes, donor2	11799-124C8	24.62	6.99	5.76	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	16.72	7.80	5.80	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	17.86	5.10	12.50	0.77
CD14-CD16+ Monocytes, donor2	11800-124C9	24.37	6.59	8.34	0.44
CD14-CD16+ Monocytes, donor3	11911-125G3	23.58	4.63	9.26	0.63
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	58.94	4.06	20.32	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	52.20	6.10	12.20	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	52.82	15.53	23.82	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	66.63	15.99	24.52	1.60
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	55.75	15.01	18.76	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	44.92	11.23	21.06	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	47.85	7.84	21.96	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	58.00	10.55	19.77	0.00
CD19+ B Cells, donor1	11544-120B5	32.05	5.75	15.62	0.00
CD19+ B Cells, donor2	11624-122B4	29.02	5.80	10.88	0.73
CD19+ B Cells, donor3	11705-123B4	24.74	4.54	13.63	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	87.68	21.82	9.29	2.42
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	73.91	19.18	5.59	0.00
CD34+ Progenitors, donor1	11545-120B6	17.07	3.01	12.05	0.00
CD34+ Progenitors, donor2	11625-122B5	28.09	1.12	6.74	2.25
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	41.71	11.27	9.77	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	42.62	10.15	11.05	0.23
CD4+ T Cells, donor1	11225-116C1	47.49	6.78	10.71	0.71
CD4+ T Cells, donor2	11306-117C1	28.17	5.51	6.74	2.45
CD4+ T Cells, donor3	11382-118B5	27.45	4.57	10.37	1.83
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	53.60	19.65	8.17	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	50.53	21.79	9.43	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	49.16	19.83	6.32	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	53.57	11.38	17.54	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	61.10	9.13	25.28	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	52.74	6.59	16.48	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	48.12	16.91	9.10	0.58
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	29.49	14.57	7.29	0.51
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	28.21	14.99	6.13	0.81
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	48.86	8.97	13.00	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	52.06	5.94	10.83	2.10
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	61.16	11.88	9.24	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	59.45	18.55	10.96	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	26.18	14.34	9.35	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	32.41	13.37	9.36	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	58.19	9.52	14.68	1.09
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	74.50	19.29	18.76	1.07
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	43.04	5.38	14.35	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	47.10	17.80	11.50	0.37
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	43.32	16.25	8.88	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	43.92	15.97	9.25	1.05
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	38.43	11.12	11.63	1.52
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	45.49	12.56	11.26	1.30
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	57.53	14.38	10.46	1.74
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	59.88	22.27	14.85	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	60.01	12.92	8.31	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	65.60	9.77	13.96	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	89.45	13.57	17.45	0.55
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	71.41	9.32	18.16	0.49
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	78.54	23.10	21.56	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	60.88	16.83	11.46	0.72
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	51.24	8.31	11.08	0.00
CD8+ T Cells, donor1	11226-116C2	30.12	3.93	6.22	1.64
CD8+ T Cells, donor2	11307-117C2	22.53	2.25	3.38	0.38
CD8+ T Cells, donor3	11383-118B6	28.78	3.79	7.32	2.27
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	20.65	7.34	3.90	1.84
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	21.09	6.47	3.12	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	21.34	6.02	4.10	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	32.72	8.11	5.40	1.20
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	22.32	4.80	4.32	0.48
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	18.87	6.14	4.78	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	24.55	7.60	3.26	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	23.69	8.95	2.63	0.79
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	24.86	6.80	2.81	0.70
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	26.87	9.36	3.92	0.60
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	19.75	7.55	3.20	0.87
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	26.91	5.60	2.40	0.80
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	18.82	3.06	1.75	1.75
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	16.40	2.28	2.73	0.91
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	17.16	3.73	1.49	1.49
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	24.49	6.12	6.84	1.08
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	22.73	8.92	2.30	0.58
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	19.56	7.54	4.24	1.41
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	25.67	9.82	2.22	1.58
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	24.30	12.61	3.69	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	31.10	5.45	2.89	1.28
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	22.95	6.12	3.44	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	22.86	3.94	3.55	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	27.23	5.29	2.27	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	31.32	4.82	10.44	2.41
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	27.98	8.39	11.89	4.20
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	28.05	6.01	4.01	3.01
Cardiac Myocyte, donor1	11525-119I4	18.28	1.83	9.14	0.00
Cardiac Myocyte, donor2	11605-120I3	14.33	3.46	5.43	0.49
Cardiac Myocyte, donor3	11686-122I3	23.78	3.89	4.31	0.95
Chondrocyte - de diff, donor1	11261-116G1	36.40	6.24	5.20	0.35
Chondrocyte - de diff, donor2	11338-117F6	27.72	3.91	7.11	0.36
Chondrocyte - de diff, donor3	11410-118E6	14.22	6.03	9.78	0.57
Chondrocyte - re diff, donor2	11339-117F7	62.67	12.53	11.64	3.58
Chondrocyte - re diff, donor3	11411-118E7	16.18	4.45	5.66	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	32.25	5.51	8.61	1.15
Ciliary Epithelial Cells, donor2	11323-117D9	19.03	5.13	3.63	0.86
Ciliary Epithelial Cells, donor3	11399-118D4	19.91	4.87	6.28	0.62
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	24.58	6.05	11.83	0.64
Corneal Epithelial Cells, donor1	11526-119I5	5.05	0.44	0.88	0.00
Corneal Epithelial Cells, donor2	11606-120I4	9.10	0.00	3.41	0.00
Corneal Epithelial Cells, donor3	11687-122I4	4.09	2.30	0.77	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	29.55	16.18	5.94	3.14
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	32.49	11.67	8.52	1.26
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	44.86	10.35	6.90	3.45
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	19.76	10.15	7.02	0.97
Dendritic Cells - plasmacytoid, donor1	11228-116C4	20.84	4.78	4.78	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	23.50	5.88	3.92	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	21.29	2.42	4.84	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	22.51	10.17	3.17	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	12.32	4.69	5.28	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	16.40	4.24	2.83	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	16.91	7.86	1.97	0.39
Endothelial Cells - Artery, donor1	11264-116G4	14.25	4.36	0.00	0.29
Endothelial Cells - Artery, donor2	11341-117F9	11.06	3.06	1.88	0.71
Endothelial Cells - Artery, donor3	11413-118E9	14.55	4.73	4.56	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	31.70	7.76	5.10	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	35.60	9.43	6.69	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	44.54	7.33	3.95	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	12.18	1.19	3.86	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	21.35	5.21	4.17	1.04
Endothelial Cells - Microvascular, donor3	11414-118F1	6.52	2.13	3.97	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	36.81	6.80	4.40	1.20
Endothelial Cells - Thoracic, donor2	11343-117G2	6.29	4.72	1.05	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	41.00	11.43	11.80	1.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	16.95	6.52	8.47	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	20.88	4.89	6.84	0.24
Endothelial Cells - Vein, donor1	11267-116G7	12.51	6.83	4.55	0.00
Endothelial Cells - Vein, donor2	11344-117G3	9.78	4.19	0.00	0.70
Endothelial Cells - Vein, donor3	11416-118F3	13.03	4.08	4.08	0.31
Eosinophils, donor1	12244-129H3	0.00	0.00	15.25	0.00
Eosinophils, donor2	12245-129H4	79.21	9.90	11.55	11.55
Eosinophils, donor3	12246-129H5	64.20	7.13	3.57	21.40
Esophageal Epithelial Cells, donor1	11507-119G4	3.18	1.95	0.49	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	2.08	0.00	2.08	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	16.27	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	19.29	7.80	5.34	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	13.69	4.49	5.36	0.77
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	25.57	8.34	6.39	0.98
Fibroblast - Aortic Adventitial, donor1	11245-116E3	44.63	11.89	4.97	3.40
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	42.85	7.37	11.05	8.73
Fibroblast - Aortic Adventitial, donor2	11326-117E3	27.21	7.59	6.75	2.21
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	24.50	3.16	7.90	3.16
Fibroblast - Aortic Adventitial, donor3	11401-118D6	23.59	7.97	6.31	0.66
Fibroblast - Cardiac, donor1	11268-116G8	24.95	2.27	3.63	1.36
Fibroblast - Cardiac, donor2	11345-117G4	18.95	1.52	4.55	0.00
Fibroblast - Cardiac, donor3	11417-118F4	8.99	2.84	3.15	0.95
Fibroblast - Cardiac, donor4	11452-119A3	37.59	11.52	7.58	1.82
Fibroblast - Cardiac, donor5	11456-119A7	25.38	4.19	6.60	1.02
Fibroblast - Cardiac, donor6	11460-119B2	21.53	5.00	8.03	0.45
Fibroblast - Choroid Plexus, donor1	11492-119E7	12.86	0.54	3.48	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	22.43	2.59	5.61	1.73
Fibroblast - Choroid Plexus, donor3	11653-122E6	17.58	8.79	1.46	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	12.45	1.85	2.54	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	32.06	8.48	8.48	0.85
Fibroblast - Dermal, donor1	11269-116G9	21.37	7.04	3.52	0.70
Fibroblast - Dermal, donor2	11346-117G5	38.68	10.85	5.19	0.47
Fibroblast - Dermal, donor3	11418-118F5	22.85	7.37	7.37	0.60
Fibroblast - Dermal, donor4	11450-119A1	29.96	4.97	7.23	0.23
Fibroblast - Dermal, donor5	11454-119A5	33.32	4.88	10.64	0.52
Fibroblast - Dermal, donor6	11458-119A9	37.84	7.63	8.12	1.62
Fibroblast - Gingival, donor1	11237-116D4	35.19	12.08	9.37	0.83
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	42.44	11.53	10.74	7.86
Fibroblast - Gingival, donor2	11318-117D4	25.96	7.25	6.06	0.66
Fibroblast - Gingival, donor3	11394-118C8	32.10	9.96	8.90	0.48
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	23.89	13.51	10.39	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	18.68	4.93	7.05	0.53
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	32.27	8.57	10.60	0.78
Fibroblast - Gingival, donor6 (control)	11922-125H5	30.56	7.57	8.52	0.41
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	19.06	3.88	7.41	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	30.42	9.51	11.26	1.61
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	32.45	9.14	11.86	1.09
Fibroblast - Gingival, donor8 (control)	11926-125H9	28.63	7.46	11.41	1.86
Fibroblast - Gingival, donor9 (control)	11927-125I1	24.21	6.02	11.45	0.15
Fibroblast - Lung, donor1	11270-116H1	10.87	2.72	5.44	0.00
Fibroblast - Lung, donor2	11347-117G6	28.35	5.97	2.98	0.00
Fibroblast - Lung, donor3	11419-118F6	10.55	4.01	4.22	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	11.66	4.17	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	2.80	2.80	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	1.68	0.28	0.28	0.28
Fibroblast - Mammary, donor1	11540-120B1	13.40	5.28	2.84	0.00
Fibroblast - Mammary, donor2	11620-122A9	3.99	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	5.96	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	37.44	9.31	4.07	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	29.58	8.49	6.52	0.30
Fibroblast - Periodontal Ligament, donor3	11395-118C9	52.63	17.14	9.18	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	15.65	3.43	6.87	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	28.62	8.64	7.56	3.51
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	16.93	4.99	7.31	0.46
Fibroblast - Pulmonary Artery, donor1	11250-116E8	30.84	7.74	3.65	0.99
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	7.52	1.63	1.42	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	7.35	0.00	2.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	17.00	4.74	6.33	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	25.20	3.18	8.53	2.58
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	40.32	9.24	8.53	1.07
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	46.31	11.63	6.50	0.59
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	21.96	3.91	10.83	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	43.61	7.12	5.94	0.76
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	25.81	4.05	9.87	2.28
Fibroblast - skin normal, donor1	11553-120C5	38.56	7.38	8.86	1.64
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	29.68	9.02	9.82	2.01
Fibroblast - skin normal, donor2	11561-120D4	43.80	7.64	6.23	1.11
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	26.90	4.23	6.95	1.51
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	42.58	11.68	12.26	0.66
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	42.74	6.15	10.77	1.20
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	25.95	2.96	6.57	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	36.96	7.14	7.46	1.60
Fibroblast - skin walker warburg, donor1	11554-120C6	35.93	6.92	5.57	0.51
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	26.19	8.63	6.90	0.47
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	66.48	155.12	0.00	22.16
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	20.92	16.56	13.07	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	24.96	7.28	6.59	1.04
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	28.37	8.07	7.03	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	27.08	7.67	4.60	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	17.61	2.30	8.42	2.30
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	25.52	3.19	8.93	3.19
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	23.96	2.28	3.99	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	17.10	1.10	7.45	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	23.29	4.79	5.02	1.83
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	19.42	1.78	3.76	0.20
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	20.62	3.70	7.14	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	21.20	3.59	5.54	1.30
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	22.11	3.54	2.21	1.77
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	23.32	5.37	5.09	0.99
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	18.47	3.08	4.06	0.99
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	21.76	2.95	4.57	1.88
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	17.59	2.48	2.60	0.87
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	22.29	3.46	3.74	1.94
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	26.02	2.85	3.46	1.22
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	16.89	2.97	1.83	0.68
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	21.80	2.24	2.99	0.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	19.45	2.84	3.93	0.87
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	18.91	1.77	2.36	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	23.53	2.38	3.66	1.43
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	19.21	2.90	3.80	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	19.76	2.02	4.03	1.21
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	25.11	2.71	4.07	1.19
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	36.71	6.47	4.43	2.13
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	38.29	4.68	7.39	1.04
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	39.96	4.78	5.81	1.20
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	24.57	2.55	6.53	1.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	34.53	4.33	4.33	0.92
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	40.22	4.08	3.68	3.27
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	21.46	2.27	3.92	0.62
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	26.40	3.69	4.61	0.69
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	26.02	3.34	3.50	0.83
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	24.03	3.97	3.75	0.88
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	24.48	3.20	6.76	0.49
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	24.64	1.95	3.08	1.30
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	27.58	4.49	5.77	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	19.52	2.84	4.93	0.19
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	23.57	2.53	5.06	1.11
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	22.81	4.56	3.65	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	27.39	3.66	4.50	0.73
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	23.05	3.73	7.90	0.88
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	20.48	3.65	4.77	1.12
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	23.15	5.37	5.09	0.83
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	31.02	5.35	6.95	1.34
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	24.33	5.97	4.28	1.22
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	29.15	5.44	5.18	0.78
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	29.55	3.80	5.69	1.36
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	21.57	6.27	9.22	1.11
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	26.98	6.14	6.58	1.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	21.82	2.98	6.94	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	24.27	4.62	5.80	0.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	26.03	3.83	4.44	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	47.27	7.62	11.95	1.02
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	47.97	4.38	4.78	1.19
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	25.73	5.55	2.47	0.62
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	34.17	2.45	5.73	1.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	22.84	2.50	5.95	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	23.17	2.54	4.80	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	24.91	1.84	3.69	2.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	49.50	7.42	7.42	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	27.08	4.64	7.35	1.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	22.46	3.21	9.63	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	33.04	1.74	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	18.55	4.23	5.21	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	23.47	2.06	2.47	2.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	23.33	0.00	6.66	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	20.97	2.24	4.19	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	20.59	2.94	1.96	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	33.55	2.52	1.68	2.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	28.63	3.18	6.36	0.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	18.00	1.36	5.43	1.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	39.67	4.18	4.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	26.34	2.29	4.01	1.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	15.39	2.07	2.07	0.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	27.11	8.47	15.25	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	24.44	2.07	4.56	2.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	20.02	2.07	7.36	1.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	26.34	0.00	5.27	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	21.91	2.31	4.23	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	25.10	0.65	4.24	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	21.40	4.01	3.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	26.58	3.08	3.08	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	36.29	6.16	10.27	2.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	14.91	2.48	0.00	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	25.48	3.30	2.36	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	21.12	0.60	4.22	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	19.84	1.53	3.05	1.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	21.54	2.39	3.99	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	23.68	0.99	5.43	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	28.33	1.18	5.90	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	22.17	1.75	4.08	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	22.38	2.63	3.07	2.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	22.04	0.85	7.63	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	25.07	1.19	5.97	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	21.35	0.97	6.79	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	18.26	1.14	5.71	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	9.15	3.33	1.25	0.83
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	17.99	4.50	2.25	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	22.84	5.39	7.93	0.95
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	15.87	5.85	4.60	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	27.62	11.37	6.96	2.44
Hep-2 cells mock treated, biol_rep2	11899-125E9	32.75	14.01	10.13	3.38
Hep-2 cells mock treated, biol_rep3	11900-125F1	30.94	12.06	9.10	2.50
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	32.36	12.13	9.84	3.94
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	36.11	12.25	9.24	3.44
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	27.56	11.41	7.10	1.94
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	20.30	11.21	6.73	1.74
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	24.36	11.32	6.00	2.92
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	20.50	9.29	9.29	4.16
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	9.51	1.68	3.92	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	5.19	0.00	1.30	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	18.51	2.64	2.64	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	5.29	2.12	1.06	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	5.09	0.00	0.73	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	18.01	7.17	3.50	0.17
Hepatocyte, donor1	11523-119I2	12.11	7.26	13.32	1.21
Hepatocyte, donor2	11603-120I1	14.01	8.62	10.77	2.15
Hepatocyte, donor3	11684-122I1	11.04	9.20	14.11	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	33.94	8.48	13.05	1.96
Intestinal epithelial cells (polarized), donor1	11246-116E4	45.27	15.91	9.61	0.87
Iris Pigment Epithelial Cells, donor1	11530-119I9	23.19	5.21	4.39	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	6.37	9.55	25.47	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	13.35	0.00	40.05	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	27.08	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	12.46	1.38	15.23	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	20.02	2.50	12.51	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	0.00	23.74	11.87
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	5.13	2.56	33.32	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	0.00	0.00	9.14	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	38.98	8.12	30.86	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	18.34	1.67	10.00	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	0.00	3.63	18.15	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	21.18	5.29	17.21	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	15.52	3.33	9.98	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	10.48	0.00	36.67	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	14.49	4.41	17.01	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	7.73	9.28	23.20	3.09
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	43.90	0.00	29.27	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	18.74	1.29	31.66	1.29
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	19.32	3.22	43.47	4.83
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	0.00	107.53	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	15.48	4.07	39.93	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	9.24	4.20	27.29	1.26
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	0.00	14.37	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	13.66	6.43	39.38	2.41
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	14.77	3.69	22.16	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	15.08	90.48	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	14.16	4.72	23.60	0.94
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	12.70	0.00	24.49	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	73.71	0.00	103.20	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	13.99	6.46	44.12	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	31.76	1.27	55.90	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	65.72	16.43
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	10.84	4.46	45.91	1.28
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	12.76	1.82	38.28	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	15.80	94.83	15.80
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	13.57	2.86	36.42	1.43
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	13.27	0.00	43.14	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	62.55	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	20.99	4.63	15.43	0.93
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	17.56	5.27	17.56	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	12.57	6.29	31.43	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	19.47	9.74	34.07	2.78
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	28.77	2.21	15.49	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	12.97	0.00	29.18	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	12.21	7.85	18.31	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	24.75	2.25	20.25	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	6.97	0.00	27.88	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	12.80	7.47	11.73	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	9.70	1.39	26.32	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	28.50	0.00	31.35	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	9.20	2.76	29.45	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	21.18	6.05	9.08	3.03
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	18.63	0.00	12.42	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	15.86	1.06	24.32	0.00
Keratinocyte - epidermal, donor1	11272-116H3	25.87	7.02	4.98	0.90
Keratinocyte - epidermal, donor2	11349-117G8	15.23	4.69	2.34	0.59
Keratinocyte - epidermal, donor3	11421-118F8	26.60	7.86	4.92	0.57
Keratinocyte - oral, donor1	11251-116E9	48.24	10.56	7.95	0.34
Keratocytes, donor1	11527-119I6	20.29	2.06	3.44	0.00
Keratocytes, donor2	11607-120I5	2.34	1.17	1.17	0.00
Keratocytes, donor3	11688-122I5	18.77	4.94	3.36	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	10.99	4.40	2.20	0.00
Lens Epithelial Cells, donor1	11529-119I8	15.10	1.08	4.31	0.00
Lens Epithelial Cells, donor2	11609-120I7	30.33	6.00	3.58	0.81
Lens Epithelial Cells, donor3	11690-122I7	20.28	3.03	4.64	0.61
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	19.80	7.47	3.20	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	11.72	2.23	1.40	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	24.87	6.77	5.19	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	16.13	4.30	4.30	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	10.40	1.89	1.26	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	10.78	3.88	3.45	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	17.24	5.34	2.05	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	7.33	1.77	3.29	0.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	11.40	3.10	2.53	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	17.40	3.96	1.19	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	11.83	3.10	3.68	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	7.41	1.30	1.48	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	14.29	4.88	3.83	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	12.64	4.05	3.34	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	7.83	3.43	3.02	0.41
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	20.63	3.39	4.62	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	7.79	2.81	1.56	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	10.25	2.20	2.38	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	12.18	1.97	3.62	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	8.49	2.05	3.22	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	7.47	1.74	0.75	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	20.37	4.85	2.91	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	13.46	3.50	2.69	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	13.17	3.63	3.48	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	15.03	4.15	2.59	1.04
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	18.01	2.93	3.35	1.47
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	12.03	2.56	2.86	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	23.39	8.94	2.06	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	9.22	4.52	3.01	0.56
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	7.74	1.38	2.12	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	15.51	4.85	1.94	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	12.57	2.32	1.65	0.99
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	11.52	1.61	1.86	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	27.77	5.18	2.96	1.11
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	10.87	3.71	2.22	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	9.21	2.20	1.92	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	25.73	4.82	3.22	1.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	15.83	3.35	3.35	0.91
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	20.16	4.76	3.50	0.56
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	18.49	3.91	1.42	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	11.15	2.91	1.45	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	8.56	2.49	2.18	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	22.56	6.45	3.94	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	14.37	3.59	3.27	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	8.48	2.35	2.12	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	30.07	6.44	2.85	0.62
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	7.68	2.82	1.54	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	9.25	2.09	1.49	0.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	15.86	4.53	2.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	12.27	3.84	10.74	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	17.07	5.20	5.94	2.97
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	13.96	6.35	13.54	2.54
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	9.14	5.63	9.14	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	11.21	2.80	8.41	2.80
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	12.88	4.12	8.76	2.06
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	9.52	2.38	9.52	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	13.57	3.85	10.63	2.26
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	18.61	5.23	10.18	0.87
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	19.81	6.30	10.35	3.60
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	16.39	6.37	8.81	2.17
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	15.41	3.59	8.73	1.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	14.11	6.35	6.70	1.06
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	17.32	4.00	8.66	3.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	14.77	6.62	7.64	1.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	14.41	6.67	9.61	1.60
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	17.95	6.42	11.15	1.51
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	15.34	5.52	11.66	3.07
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	16.31	4.89	12.23	2.45
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	17.28	9.16	12.08	3.54
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	19.06	7.57	4.76	2.52
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	15.46	3.09	8.24	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	16.55	7.55	10.16	2.03
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	20.93	8.97	8.37	2.09
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	13.28	6.09	7.75	1.66
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	18.73	8.13	7.78	2.83
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	23.97	8.48	6.64	5.53
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	18.42	3.45	5.76	2.30
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	14.97	4.22	7.68	2.30
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	16.42	9.06	5.10	3.96
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	17.23	12.31	9.85	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	13.56	8.13	5.87	1.36
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	19.39	10.05	6.46	2.87
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	13.44	7.47	8.96	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	16.35	4.83	8.55	0.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	19.81	6.89	9.05	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	19.69	4.28	6.85	2.57
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	11.99	5.66	8.66	3.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	15.08	7.84	4.83	1.21
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	14.22	7.82	7.82	1.42
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	14.09	7.91	5.84	2.41
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	16.10	5.37	6.44	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	10.10	6.06	5.39	2.02
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	22.22	9.63	4.44	1.85
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	18.61	8.14	8.14	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	9.52	4.23	5.29	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	17.61	6.00	6.80	2.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	10.18	5.09	10.18	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	13.03	7.67	9.96	2.30
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	14.31	7.40	12.33	1.48
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	10.35	4.70	3.76	4.70
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	13.58	6.54	8.05	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	13.07	6.76	7.66	2.70
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	29.26	6.88	6.88	3.44
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	15.14	2.67	12.91	1.78
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	17.21	10.17	5.87	2.74
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	13.85	5.94	5.94	1.98
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	11.94	6.23	12.45	1.56
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	16.63	7.00	6.56	3.50
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	15.65	5.59	8.39	1.68
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	16.78	4.86	12.81	1.77
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	18.51	8.49	6.17	3.09
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	18.74	7.09	9.11	2.53
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	16.82	8.65	8.17	1.92
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	15.90	3.98	8.35	2.78
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	18.23	9.72	6.68	2.43
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	19.37	6.92	4.84	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	20.90	6.08	5.70	4.18
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	19.62	9.30	3.10	6.71
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	13.30	9.07	5.44	3.63
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	25.99	9.19	8.87	3.17
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	22.39	8.00	6.93	2.67
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	17.24	2.30	6.90	3.45
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	20.57	5.14	5.66	3.09
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	26.88	12.03	4.95	4.24
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	26.67	6.81	3.97	1.70
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	14.98	9.15	3.33	1.66
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	25.84	6.26	4.70	2.35
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	20.46	7.10	7.52	3.34
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	20.91	6.97	6.50	4.18
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	22.08	9.37	5.35	4.01
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	24.06	4.81	5.88	2.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	17.78	6.47	5.25	2.02
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	10.10	5.51	2.75	1.84
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	17.78	5.33	1.78	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	21.66	10.83	6.27	2.28
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	18.41	8.44	6.14	1.53
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	20.79	4.38	1.64	2.19
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	20.05	10.69	4.01	2.23
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	29.11	9.36	3.90	1.56
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	22.55	13.93	5.97	1.99
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	14.55	10.39	8.31	2.08
Macrophage - monocyte derived, donor1	11232-116C8	29.63	13.22	4.56	0.46
Macrophage - monocyte derived, donor2	11313-117C8	22.94	11.19	3.85	0.37
Macrophage - monocyte derived, donor3	11389-118C3	19.79	8.26	7.21	0.52
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	25.49	6.90	5.84	1.06
Mallassez-derived cells, donor2	11929-125I3	40.88	8.87	6.18	0.95
Mallassez-derived cells, donor3	11930-125I4	42.53	10.98	6.81	1.53
Mammary Epithelial Cell, donor1	11273-116H4	65.86	21.02	10.26	2.39
Mammary Epithelial Cell, donor2	11350-117G9	64.28	12.16	5.79	0.87
Mammary Epithelial Cell, donor3	11422-118F9	11.47	3.99	4.24	0.00
Mast cell - stimulated, donor1	11487-119E2	94.23	22.37	8.14	10.85
Mast cell, donor1	11563-120D6	54.39	16.76	7.03	1.51
Mast cell, donor2	11565-120D8	31.50	8.02	4.16	0.30
Mast cell, donor3	11566-120D9	31.74	10.58	8.33	1.13
Mast cell, donor4	11567-120E1	30.14	7.09	10.64	0.71
Mast cell, expanded and stimulated, donor5	11940-126A5	57.33	20.40	6.54	0.44
Mast cell, expanded and stimulated, donor8	11942-126A7	42.61	11.67	11.09	1.17
Mast cell, expanded, donor5	11939-126A4	57.48	20.08	7.46	0.69
Mast cell, expanded, donor8	11941-126A6	34.81	14.39	15.06	0.67
Melanocyte - dark, donor1	11502-119F8	27.26	5.87	4.78	0.90
Melanocyte - dark, donor2	11582-120F7	16.96	4.15	5.19	0.35
Melanocyte - dark, donor3	11663-122F7	46.07	8.84	10.72	0.72
Melanocyte - light, donor1	11274-116H5	15.75	3.29	3.53	0.47
Melanocyte - light, donor2	11351-117H1	15.01	0.68	6.14	0.68
Melanocyte - light, donor3	11423-118G1	7.81	1.73	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	35.30	9.27	7.71	0.73
Melanocyte, donor2 (MC+2)	12739-135I3	25.82	4.30	6.72	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	40.71	8.30	20.89	3.21
Meningeal Cells, donor1	11493-119E8	19.48	2.85	1.86	0.25
Meningeal Cells, donor2	11573-120E7	11.44	1.32	3.52	0.44
Meningeal Cells, donor3	11654-122E7	49.15	9.54	6.52	1.55
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	29.09	10.27	3.99	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	33.91	9.96	6.04	1.11
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	2.63	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	3.92	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	21.53	8.61	2.87	1.44
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	35.79	9.53	5.72	0.64
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	18.10	7.54	7.54	2.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	9.67	0.88	1.54	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	5.11	2.19	2.19	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	4.71	2.86	0.41	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	29.23	6.93	3.60	0.42
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	6.69	0.37	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	26.45	7.63	1.45	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	6.83	2.67	1.19	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	2.34	0.00	2.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	7.68	0.64	2.56	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	44.31	16.30	4.61	1.06
Mesenchymal stem cells - hepatic, donor0	11218-116B3	19.39	6.57	1.56	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	21.77	5.81	3.63	0.00
Mesothelial Cells, donor1	11247-116E5	36.59	10.34	5.83	2.12
Mesothelial Cells, donor2	12156-128G5	20.02	9.51	8.51	1.00
Mesothelial Cells, donor3	11402-118D7	16.48	5.78	6.87	0.87
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	8.10	1.35	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	25.86	8.62	7.63	0.99
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	20.91	8.83	6.18	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	3.46	3.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	29.13	11.78	4.65	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	20.54	9.75	6.02	1.04
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	6.95	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	17.52	9.01	6.01	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	12.10	10.24	5.12	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	19.51	4.88	5.49	1.02
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	15.44	5.15	4.75	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	8.55	8.55	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	22.12	2.65	3.54	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	23.56	12.16	5.32	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	3.95	2.63	1.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	16.55	8.28	5.52	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	4.60	1.84	5.52	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	9.84	5.66	4.17	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	13.41	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	15.05	9.53	5.52	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	15.69	8.56	4.75	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	8.85	1.66	3.32	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	15.43	7.14	4.60	1.38
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	14.30	8.20	4.84	0.42
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	11.41	7.13	2.45	2.04
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	18.45	8.37	5.58	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	11.78	4.00	5.78	1.78
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	10.32	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	15.77	6.57	3.29	2.19
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	12.17	2.53	2.53	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	3.31	4.97	4.97	1.66
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	17.94	4.35	4.35	0.82
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	14.41	5.29	5.00	1.18
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	6.54	0.00	5.45	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	20.66	3.84	2.88	1.92
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	18.81	7.60	8.00	3.60
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	13.71	2.74	9.60	1.37
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	32.04	7.51	3.50	1.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	26.95
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	4.08	0.00	6.12	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	25.84	6.13	1.31	2.19
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	5.52	1.10	12.14	1.10
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	9.61	1.92	6.40	1.28
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	32.97	8.43	5.70	2.23
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	11.13	1.39	4.87	1.39
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	8.84	2.21	11.05	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	25.98	6.84	5.81	2.05
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	15.32	3.50	11.38	1.75
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	9.23	2.49	5.68	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	27.77	10.38	7.86	2.81
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	30.76	4.16	6.23	2.49
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	6.99	1.75	4.66	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	19.61	5.43	3.32	2.11
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	34.23	11.27	5.43	3.76
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	21.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	32.32	5.54	5.54	2.77
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	22.76	5.12	6.83	3.98
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	13.96	3.73	3.73	0.83
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	29.28	6.22	4.66	2.85
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	23.16	4.29	3.43	1.72
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	6.35	1.27	5.72	1.27
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	20.55	5.60	5.60	0.53
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	30.83	9.88	6.29	1.50
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	12.85	3.39	3.53	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	26.76	8.92	3.19	3.19
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	31.18	9.95	5.53	3.10
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	9.48	2.28	3.41	0.76
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	27.27	9.38	5.40	1.99
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	34.90	9.34	7.13	3.69
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	11.73	1.96	4.56	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	22.93	6.17	4.70	1.18
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	31.43	5.48	7.78	1.44
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	11.95	3.71	3.30	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	28.88	9.53	7.74	0.60
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	15.07	3.77	3.77	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	17.82	10.69	3.56	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	25.96	7.89	8.54	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	22.09	4.21	7.36	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	31.83	10.68	2.97	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	25.15	5.59	6.52	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	31.17	7.51	10.51	0.75
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	17.05	8.26	6.13	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	34.27	9.50	5.43	0.34
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	14.73	8.10	8.84	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	24.55	9.53	9.16	0.73
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	24.89	10.89	3.11	3.11
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	40.62	11.76	8.02	2.14
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	19.32	3.86	3.86	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	20.20	6.06	7.07	2.02
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	24.88	8.43	5.90	0.84
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	62.65	10.90	36.77	4.09
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	25.43	1.91	5.72	3.18
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	37.25	4.05	13.77	3.24
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	19.64	6.04	24.17	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	268.38	34.26	199.86	34.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	150.07	16.31	71.77	9.79
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	33.27	4.75	38.02	4.75
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	125.49	12.55	87.84	37.65
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	55.15	10.99	5.82	5.17
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	40.24	9.41	6.27	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	12.01	6.01	4.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	10.85	2.50	8.35	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	28.14	6.65	5.32	1.14
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	20.75	9.58	15.96	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	18.36	4.08	7.48	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	62.48	12.86	0.00	3.68
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	14.65	6.28	8.37	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	25.10	9.53	8.83	1.86
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	16.75	2.97	8.38	0.54
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	21.65	6.10	6.94	0.84
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	89.08	22.27	22.27	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	16.38	4.96	3.47	1.49
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	23.01	5.95	7.31	1.08
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	27.66	7.71	6.57	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	14.86	3.43	6.37	0.49
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	24.24	6.38	5.29	1.28
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	19.63	4.24	12.73	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	8.40	4.20	10.81	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	26.25	5.58	8.20	2.30
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	14.80	2.76	8.13	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	23.28	5.64	7.94	1.23
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	12.66	5.63	7.03	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	17.93	2.76	6.44	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	17.67	5.78	10.60	0.96
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	27.59	3.79	6.55	2.76
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	45.51	5.06	10.11	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	18.49	5.12	9.13	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	15.67	2.12	5.50	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	13.29	5.46	4.51	1.42
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	21.03	9.87	9.44	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	171.53	27.08	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	21.33	7.00	10.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	12.62	3.61	5.41	0.90
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	20.63	7.14	5.56	1.19
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	19.50	6.50	3.71	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	27.24	9.46	6.81	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	13.04	5.21	11.08	1.30
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	13.95	2.61	9.15	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	22.61	7.69	5.88	0.90
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	22.05	5.29	4.41	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	15.29	7.31	6.65	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	18.35	7.94	11.91	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	15.31	3.83	12.25	0.77
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	35.99	8.17	6.65	0.91
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	26.74	8.84	4.64	1.33
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	21.01	8.81	2.71	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	35.77	10.22	10.22	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	29.26	4.88	14.02	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	19.51	6.29	7.55	0.63
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	15.13	5.45	7.87	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	16.61	3.16	3.96	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	30.61	4.53	5.67	2.27
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	40.46	45.52	5.06	5.06
Myoblast, donor1	11241-116D8	31.43	9.57	4.10	1.74
Myoblast, donor2	11322-117D8	24.55	11.32	7.10	0.96
Myoblast, donor3	11398-118D3	30.77	8.91	6.22	0.84
NK T cell leukemia cell line:KHYG-1	10777-110G3	38.96	9.78	4.38	0.58
Natural Killer Cells, donor1	11230-116C6	27.37	7.69	7.07	1.54
Natural Killer Cells, donor2	11311-117C6	20.20	5.13	5.43	1.21
Natural Killer Cells, donor3	11387-118C1	25.40	4.79	4.60	4.05
Neural stem cells, donor1	11275-116H6	62.79	13.43	11.98	0.73
Neural stem cells, donor2	11352-117H2	53.92	7.70	7.70	5.78
Neurons, donor1	11494-119E9	37.55	3.41	6.83	10.24
Neurons, donor2	11574-120E8	44.69	7.05	5.28	1.76
Neurons, donor3	11655-122E8	42.75	7.40	8.22	2.47
Neutrophils, donor1	11233-116C9	30.62	11.14	4.64	1.86
Neutrophils, donor2	11314-117C9	17.39	11.60	2.90	0.00
Neutrophils, donor3	11390-118C4	40.32	7.33	7.94	1.83
Nucleus Pulposus Cell, donor1	11252-116F1	32.06	6.41	7.60	0.71
Nucleus Pulposus Cell, donor2	11409-118E5	11.40	1.95	4.88	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	18.85	3.81	5.41	0.20
Olfactory epithelial cells, donor1	11933-125I7	21.06	5.23	7.43	1.38
Olfactory epithelial cells, donor2	11934-125I8	26.20	7.38	6.66	3.91
Olfactory epithelial cells, donor3	11935-125I9	29.85	8.40	11.80	2.04
Olfactory epithelial cells, donor4	11936-126A1	26.10	6.14	9.45	1.46
Oligodendrocyte - precursors, donor1	11496-119F2	24.67	9.63	5.42	2.41
Osteoblast - differentiated, donor1	11276-116H7	20.42	9.36	5.96	0.85
Osteoblast - differentiated, donor2	11353-117H3	5.72	1.14	4.57	0.00
Osteoblast - differentiated, donor3	11425-118G3	14.90	1.86	6.21	0.00
Osteoblast, donor1	11277-116H8	14.85	4.89	5.08	0.98
Osteoblast, donor2	11354-117H4	63.21	7.73	2.11	1.40
Osteoblast, donor3	11426-118G4	23.10	4.80	6.22	0.36
Pancreatic stromal cells, donor1	11249-116E7	40.94	14.40	8.93	1.01
Pericytes, donor1	11491-119E6	3.67	0.22	1.11	0.11
Pericytes, donor2	11571-120E5	3.62	0.23	1.81	0.00
Pericytes, donor3	11652-122E5	5.29	2.03	1.83	0.00
Perineurial Cells, donor1	11499-119F5	29.61	5.54	4.07	0.34
Perineurial Cells, donor2	11579-120F4	23.09	6.44	6.90	0.37
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	26.14	7.97	8.29	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	16.90	5.39	8.33	1.47
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	15.40	5.31	7.64	0.78
Placental Epithelial Cells, donor1	11278-116H9	16.74	4.78	4.54	1.67
Placental Epithelial Cells, donor2	11355-117H5	12.20	4.44	3.33	0.00
Placental Epithelial Cells, donor3	11427-118G5	7.46	2.55	5.89	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	19.62	6.65	11.08	1.90
Preadipocyte - breast, donor1	11467-119B9	36.39	9.38	7.88	3.94
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	39.03	6.00	6.00	9.92
Preadipocyte - breast, donor2	11328-117E5	24.32	7.20	11.48	3.15
Preadipocyte - omental, donor1	11468-119C1	43.05	13.85	13.64	3.52
Preadipocyte - omental, donor2	11329-117E6	40.16	15.28	7.86	4.36
Preadipocyte - omental, donor3	11403-118D8	23.35	5.73	7.59	2.44
Preadipocyte - perirenal, donor1	11469-119C2	20.67	2.95	4.92	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	14.43	8.60	3.07	1.23
Preadipocyte - subcutaneous, donor2	11356-117H6	28.86	10.98	2.66	0.71
Preadipocyte - subcutaneous, donor3	11428-118G6	21.29	5.79	4.43	1.02
Preadipocyte - visceral, donor1	11280-116I2	49.37	16.77	6.33	1.49
Preadipocyte - visceral, donor2	11357-117H7	27.15	12.89	5.98	1.38
Preadipocyte - visceral, donor3	11429-118G7	21.00	6.16	3.45	0.84
Prostate Epithelial Cells (polarized), donor1	11253-116F2	45.41	10.11	4.37	1.66
Prostate Epithelial Cells, donor2	11331-117E8	14.90	5.15	3.11	0.00
Prostate Epithelial Cells, donor3	11404-118D9	14.21	5.51	3.18	0.00
Prostate Stromal Cells, donor1	11254-116F3	36.68	10.48	5.58	0.46
Prostate Stromal Cells, donor2	11332-117E9	24.38	6.81	4.12	1.26
Prostate Stromal Cells, donor3	11405-118E1	21.38	5.01	5.32	0.31
Renal Cortical Epithelial Cells, donor1	11516-119H4	6.20	1.09	0.73	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	26.20	5.75	1.66	0.28
Renal Epithelial Cells, donor1	11517-119H5	1.01	0.51	1.01	0.00
Renal Epithelial Cells, donor2	11597-120H4	4.98	1.42	2.13	0.00
Renal Epithelial Cells, donor3	11678-122H4	25.41	5.50	2.33	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	2.72	0.68	0.00	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	6.20	1.08	2.83	0.40
Renal Glomerular Endothelial Cells, donor3	11675-122H1	19.09	5.99	1.78	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	1.33	1.33	0.67	0.00
Renal Mesangial Cells, donor1	11518-119H6	3.52	1.10	0.66	0.00
Renal Mesangial Cells, donor2	11598-120H5	2.51	1.88	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	1.11	0.28	0.83	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	14.49	2.95	1.88	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	3.80	1.27	1.27	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	4.44	1.54	1.93	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	24.37	8.82	3.11	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	7.96	0.57	1.42	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	0.00	0.00	2.06	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	31.36	6.02	9.53	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	19.64	9.35	9.62	0.27
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	40.20	16.08	4.47	1.79
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	73.75	20.91	4.95	4.95
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	67.29	13.92	6.96	4.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	36.80	7.28	3.12	2.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	21.35	8.04	5.06	1.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	47.96	13.72	7.92	4.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	43.42	9.30	6.20	3.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	27.97	8.62	5.83	1.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	27.04	10.86	6.24	2.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	21.63	4.11	5.34	1.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	22.09	7.71	5.90	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	40.50	8.60	6.81	1.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	32.56	6.89	5.45	2.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	25.11	8.16	3.86	0.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	30.09	9.74	5.53	4.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	23.90	7.07	4.01	2.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	21.43	9.41	4.75	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	49.61	17.10	9.77	4.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	24.95	3.58	5.71	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	22.39	7.20	6.42	1.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	32.84	10.12	8.40	2.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	28.41	4.81	5.45	2.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	22.70	6.73	3.92	3.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	26.32	9.91	4.79	1.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	22.61	4.56	6.56	1.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	22.20	5.76	5.03	1.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	29.95	9.54	7.79	2.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	35.15	9.67	3.77	1.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	23.02	7.54	6.15	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	29.46	7.48	7.95	3.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	29.44	5.81	6.64	1.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	26.32	7.30	7.96	2.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	27.15	6.06	7.73	1.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	28.67	6.59	7.81	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	20.61	4.09	8.17	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	25.06	9.25	7.71	2.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	34.39	7.91	5.16	1.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	20.03	5.49	6.17	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	24.46	11.49	6.24	3.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	34.43	6.48	4.26	2.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	32.11	9.62	5.03	2.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	27.45	8.53	5.60	2.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	31.80	5.95	5.25	3.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	28.57	9.05	6.19	2.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	36.68	10.08	6.05	5.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	35.69	6.87	6.22	3.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	42.27	9.43	8.38	2.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	32.64	12.69	6.35	3.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	36.23	6.49	5.51	2.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	81.80	17.18	14.70	6.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	39.55	12.78	7.30	3.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	41.29	7.23	5.43	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	35.29	9.27	5.88	3.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	38.04	8.99	5.99	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	58.45	8.50	7.91	3.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	31.59	10.46	5.34	2.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	42.07	9.01	8.41	3.61
Schwann Cells, donor1	11498-119F4	3.57	0.19	2.07	0.00
Schwann Cells, donor2	11578-120F3	37.43	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	16.43	5.92	1.75	0.88
Sebocyte, donor1	11220-116B5	23.55	3.83	2.19	1.10
Sebocyte, donor2	11301-117B5	13.33	9.19	2.30	0.00
Sebocyte, donor3	11378-118B1	15.25	4.12	3.30	0.00
Sertoli Cells, donor1	11255-116F4	36.45	23.19	4.97	1.66
Sertoli Cells, donor2	11333-117F1	19.77	2.82	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	29.74	4.31	5.72	0.26
Skeletal Muscle Cells, donor2	11358-117H8	8.67	3.61	6.51	2.89
Skeletal Muscle Cells, donor3	11430-118G8	6.69	2.51	4.18	0.00
Skeletal Muscle Cells, donor4	11451-119A2	27.49	6.44	3.30	0.16
Skeletal Muscle Cells, donor5	11455-119A6	21.11	4.16	5.20	0.30
Skeletal Muscle Cells, donor6	11459-119B1	31.24	6.46	3.23	0.31
Skeletal Muscle Satellite Cells, donor1	11240-116D7	36.79	9.07	5.67	0.38
Skeletal Muscle Satellite Cells, donor2	11321-117D7	18.41	4.85	4.85	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	26.39	8.73	5.95	0.99
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	29.91	8.00	4.21	0.93
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	10.86	5.07	6.51	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	11.01	2.89	5.64	0.96
Skin - palm, donor1	10286-104F7	24.17	8.06	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	10.24	4.04	1.15	0.43
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	78.52	20.45	18.81	4.09
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	13.11	4.02	3.12	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	33.36	9.87	5.28	0.56
Small Airway Epithelial Cells, donor2	11334-117F2	13.36	4.64	4.64	0.42
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	52.44	12.05	16.28	1.69
Small Airway Epithelial Cells, donor3	11406-118E2	11.62	3.90	5.02	0.45
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	34.25	5.25	3.39	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	20.90	2.45	4.00	1.11
Smooth Muscle Cells - Aortic, donor0	11210-116A4	23.51	4.11	6.47	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	22.32	3.98	4.42	0.44
Smooth Muscle Cells - Aortic, donor2	11360-117I1	13.78	5.91	2.76	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	15.45	8.50	3.86	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	15.01	5.00	4.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	13.84	7.45	3.73	0.53
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	19.51	5.32	3.99	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	26.76	5.63	7.81	1.79
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	35.16	6.51	6.19	1.95
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	38.10	12.11	3.54	2.36
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	16.94	4.98	2.70	1.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	3.74	0.49	0.49	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	15.53	4.26	4.26	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	14.40	5.05	3.03	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	36.72	24.48	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	9.06	2.86	2.38	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	29.64	7.82	3.39	0.59
Smooth Muscle Cells - Colonic, donor2	11320-117D6	15.28	6.03	3.23	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	21.62	6.61	2.73	0.42
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	14.85	4.95	3.40	0.93
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	11.86	6.47	2.16	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	15.54	2.69	4.18	0.90
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	5.12	2.39	2.05	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	27.41	7.07	4.24	0.08
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	34.92	14.79	6.74	1.61
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	19.57	4.78	5.46	0.46
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	9.66	2.42	1.81	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	50.60	12.98	5.30	1.32
Smooth Muscle Cells - Prostate, donor1	11257-116F6	35.95	6.66	7.32	0.53
Smooth Muscle Cells - Prostate, donor2	11335-117F3	19.28	7.26	5.01	0.75
Smooth Muscle Cells - Prostate, donor3	11465-119B7	23.08	8.37	7.36	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	30.15	9.65	4.67	0.75
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	11.25	2.25	9.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	72.36	20.68	6.46	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	24.65	5.12	4.65	0.93
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	10.60	3.53	1.51	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	14.10	3.13	5.33	2.51
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	4.72	0.29	0.88	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	35.66	10.58	3.25	0.58
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	16.82	6.07	4.67	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	15.26	7.48	2.45	1.15
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	12.49	4.59	3.82	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	9.03	1.50	2.26	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	29.21	10.06	2.24	0.42
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	26.64	5.11	2.93	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	3.33	1.43	0.95	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	18.84	5.63	2.69	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	32.26	6.41	6.19	1.55
Smooth Muscle Cells - Uterine, donor3	11466-119B8	25.16	6.73	2.34	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	19.24	5.44	3.69	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	28.30	6.08	2.64	3.17
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	29.38	4.46	2.23	1.12
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	30.54	7.91	6.11	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	24.42	9.94	3.69	0.85
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	24.81	5.12	3.54	1.97
Smooth muscle cells - airway, control, donor1	11966-126D4	24.63	6.35	2.79	0.76
Smooth muscle cells - airway, control, donor2	11967-126D5	14.38	3.19	3.59	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	22.57	5.02	2.93	1.67
Smooth muscle cells - airway, control, donor4	11969-126D7	30.71	5.04	9.63	0.46
Synoviocyte, donor1	11291-117A4	33.66	7.91	4.04	2.52
Synoviocyte, donor2	11368-117I9	14.75	3.86	7.71	1.17
Synoviocyte, donor3	11440-118H9	13.40	5.36	2.46	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	5.36	1.43	1.07	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	5.95	0.00	3.96	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	4.86	1.39	1.85	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	23.94	8.17	4.30	0.65
Tracheal Epithelial Cells, donor2	11369-118A1	11.21	1.93	5.03	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	12.60	4.01	2.86	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	29.03	9.47	10.58	0.74
Urethra, donor2	10319-105A4	14.39	7.19	16.19	0.00
Urothelial Cells, donor1	11520-119H8	3.72	0.80	0.53	0.00
Urothelial Cells, donor2	11600-120H7	2.80	2.00	0.40	0.00
Urothelial Cells, donor3	11681-122H7	1.38	0.69	0.46	0.00
Urothelial cells, donor0	11216-116B1	19.61	5.35	3.34	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	56.95	5.34	7.12	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	57.18	4.29	5.72	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	25.33	6.16	8.90	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	38.91	10.33	7.58	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	40.67	13.36	5.23	1.16
Whole blood (ribopure), donor090612, donation1	12182-129A4	59.35	11.45	4.16	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	43.14	11.01	9.18	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	21.00	11.87	10.04	0.00
Wilms' tumor cell line:G-401	10809-111A8	23.56	3.95	6.54	1.48
Wilms' tumor cell line:HFWT	10597-108E3	22.00	5.28	10.56	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	40.50	19.83	12.85	1.12
achilles tendon, donor2	10292-104G4	37.20	12.40	8.27	4.13
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	42.07	10.20	4.33	1.02
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	58.28	13.93	9.98	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	45.58	11.16	11.87	1.19
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	66.40	19.59	8.16	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	57.90	8.43	7.59	1.12
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	35.53	13.11	10.79	0.63
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	20.69	3.81	4.90	0.82
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	47.59	15.86	11.02	2.20
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	42.47	15.93	8.98	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	43.49	13.20	17.86	1.55
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	47.66	17.11	7.18	0.92
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	19.50	7.80	27.30	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	40.43	12.08	7.20	0.70
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	49.19	17.61	17.61	2.07
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	43.25	14.03	13.44	0.88
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	19.98	6.04	13.01	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	28.79	11.10	5.35	1.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	5.83	2.76	5.83	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	33.28	12.80	8.53	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	34.88	18.80	9.40	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	35.62	18.05	6.98	1.20
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	38.76	13.81	7.57	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	31.69	12.67	7.67	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	53.89	1.86	20.44	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	53.49	12.05	13.18	1.51
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	39.25	6.98	8.72	0.87
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	50.61	13.12	7.50	1.87
adenocarcinoma cell line:IM95m	10796-110I4	21.19	8.48	8.01	0.24
adipose tissue, adult, pool1	10010-101C1	28.85	9.31	7.29	0.00
adipose, donor1	10184-103D4	36.36	2.93	5.86	0.59
adipose, donor2	10185-103D5	15.82	2.43	2.84	0.41
adipose, donor3	10186-103D6	20.97	4.36	5.99	0.27
adipose, donor4	10187-103D7	61.54	15.60	0.00	2.60
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	23.04	10.57	5.84	0.16
adrenal gland, adult, pool1	10081-102A9	3.64	7.28	21.83	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	20.01	8.94	2.40	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	20.01	11.08	6.43	0.71
amniotic membrane cells, donor1	12235-129G3	28.52	10.90	13.22	0.93
amniotic membrane cells, donor2	12236-129G4	30.43	18.60	15.21	0.34
amniotic membrane cells, donor3	12237-129G5	22.68	12.37	16.50	0.59
amygdala - adult, donor10196	10167-103B5	74.71	17.79	13.04	0.00
amygdala, adult, donor10252	10151-102I7	35.69	13.18	9.33	0.20
amygdala, newborn, donor10223	10360-105E9	39.06	11.30	7.10	1.94
anaplastic carcinoma cell line:8305C	10428-106D5	35.27	9.68	4.46	0.64
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	27.36	6.40	4.85	0.66
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	47.77	7.35	9.35	3.34
aorta, adult, pool1	10052-101G7	12.36	4.31	5.49	0.78
appendix, adult	10189-103D9	23.68	8.15	12.03	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	30.61	10.32	10.32	0.00
artery, adult	10190-103E1	17.66	2.72	4.08	0.00
astrocytoma cell line:TM-31	10425-106D2	85.47	15.07	6.95	1.88
b cell line:RPMI1788	10427-106D4	29.59	7.29	3.87	0.45
basal cell carcinoma cell line:TE 354.T	10702-109G9	41.34	8.05	7.49	1.94
bile duct carcinoma cell line:HuCCT1	10432-106D9	41.68	13.79	8.14	0.69
bile duct carcinoma cell line:TFK-1	10496-107C1	27.28	12.05	1.84	0.84
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	20.13	13.42	11.74	0.56
bladder, adult, pool1	10011-101C2	22.38	5.98	4.13	0.33
blood, adult, pool1	10053-101G8	13.29	6.64	8.86	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	16.27	5.99	4.28	2.57
bone marrow, adult	10192-103E3	31.04	14.85	7.42	0.00
brain, adult, donor1	10084-102B3	16.40	7.18	3.08	0.00
brain, adult, pool1	10012-101C3	28.28	7.91	6.57	0.22
brain, fetal, pool1	10085-102B4	21.37	5.34	10.69	0.00
breast carcinoma cell line:MCF7	10482-107A5	20.48	10.57	12.55	1.98
breast carcinoma cell line:MDA-MB-453	10419-106C5	46.93	22.84	10.73	0.12
breast, adult, donor1	10080-102A8	16.42	8.21	7.58	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	29.47	25.79	17.28	0.13
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	19.17	7.73	3.09	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	24.63	15.19	1.84	0.69
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	9.20	6.78	3.63	0.48
carcinoid cell line:NCI-H1770	10703-109H1	48.90	7.52	6.11	0.00
carcinoid cell line:NCI-H727	10735-110B6	21.33	5.14	6.89	0.22
carcinoid cell line:SK-PN-DW	10719-109I8	10.14	1.90	1.58	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	41.52	6.12	11.18	0.80
caudate nucleus - adult, donor10196	10177-103C6	120.89	12.66	10.36	0.00
caudate nucleus, adult, donor10252	10164-103B2	30.96	13.05	6.53	0.00
caudate nucleus, adult, donor10258	10379-105H1	38.21	13.75	5.35	0.00
caudate nucleus, newborn, donor10223	10354-105E3	48.71	12.82	7.32	7.32
cerebellum - adult, donor10196	10173-103C2	198.10	78.66	29.13	0.00
cerebellum, adult, donor10252	10166-103B4	58.72	24.55	11.10	1.07
cerebellum, adult, pool1	10083-102B2	34.49	8.28	6.21	0.34
cerebellum, newborn, donor10223	10357-105E6	54.80	17.44	7.47	8.30
cerebral meninges, adult	10188-103D8	28.24	6.30	6.30	0.25
cerebrospinal fluid, donor2	10294-104G6	12.43	6.58	4.39	0.73
cervical cancer cell line:D98-AH2	10552-107I3	55.36	14.23	5.03	0.00
cervical cancer cell line:ME-180	10553-107I4	39.94	9.45	5.63	0.50
cervix, adult, pool1	10013-101C4	29.40	6.82	8.61	0.00
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	75.10	11.70	11.29	3.76
chondrosarcoma cell line:SW 1353	10700-109G7	9.14	1.31	10.45	0.00
choriocarcinoma cell line:BeWo	10423-106C9	44.62	13.67	11.06	1.62
choriocarcinoma cell line:SCH	10785-110H2	25.14	4.07	10.47	1.11
choriocarcinoma cell line:T3M-3	10618-108G6	20.16	4.98	3.32	0.47
chorionic membrane cells, donor1	12238-129G6	21.37	4.56	4.84	0.28
chorionic membrane cells, donor2	12239-129G7	40.97	8.35	4.47	0.80
chorionic membrane cells, donor3	12240-129G8	21.43	7.14	6.04	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	28.27	5.05	3.03	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	32.08	7.11	6.34	1.54
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	71.59	15.84	15.42	1.90
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	48.02	10.79	7.70	0.77
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	48.13	12.58	9.68	0.97
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	50.50	15.07	6.72	1.63
chronic myelogenous leukemia cell line:K562	10454-106G4	75.97	24.15	8.24	3.53
chronic myelogenous leukemia cell line:KU812	10409-106B4	83.66	18.24	18.50	2.09
clear cell carcinoma cell line:JHOC-5	10638-108I8	26.06	9.37	2.97	0.69
clear cell carcinoma cell line:TEN	10636-108I6	33.14	11.97	4.68	2.60
colon carcinoma cell line:CACO-2	10513-107D9	51.07	14.09	7.32	2.56
colon carcinoma cell line:COLO-320	10420-106C6	89.32	15.58	19.38	1.90
colon, adult, donor1	10082-102B1	13.09	4.76	4.76	0.00
colon, adult, pool1	10014-101C5	23.97	10.58	7.29	0.24
colon, fetal, donor1	10070-101I7	17.30	6.80	3.09	0.00
common myeloid progenitor CMP, donor1	12130-128D6	18.33	4.58	55.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	100.15	0.00	25.04	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	67.56	18.70	17.85	3.40
cord blood derived cell line:COBL-a 24h infection	10453-106G3	42.56	18.26	6.79	0.30
cord blood derived cell line:COBL-a untreated	10449-106F8	43.57	14.95	4.94	1.13
corpus callosum, adult, pool1	10042-101F6	28.86	10.39	10.61	0.22
cruciate ligament, donor2	10295-104G7	29.18	4.86	4.86	0.81
diaphragm, fetal, donor1	10069-101I6	16.05	2.41	4.01	1.61
diencephalon, adult	10193-103E4	19.44	8.16	5.28	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	36.97	11.02	6.89	0.92
ductal cell carcinoma cell line:KLM-1	10438-106E6	66.16	19.49	8.98	0.51
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	55.61	10.83	4.33	2.89
ductus deferens, adult	10196-103E7	21.43	11.46	13.95	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	12.96	2.88	12.96	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	36.05	6.62	9.56	0.00
dura mater, adult, donor1	10041-101F5	29.15	4.96	10.32	0.74
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	38.86	4.44	31.31	16.21
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	23.93	3.01	9.03	1.15
embryonic pancreas cell line:1B2C6	10604-108F1	20.96	4.93	8.02	1.23
embryonic pancreas cell line:1C3D3	10605-108F2	20.58	7.57	1.82	0.61
embryonic pancreas cell line:1C3IKEI	10606-108F3	24.70	5.87	2.78	0.00
embryonic pancreas cell line:2C6	10603-108E9	26.27	5.25	7.88	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	14.41	3.69	2.35	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	49.30	16.85	8.52	1.27
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	18.01	6.27	3.38	0.80
epidermoid carcinoma cell line:A431	10426-106D3	44.13	11.34	7.34	1.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	35.31	13.31	8.36	0.77
epididymis, adult	10197-103E8	20.93	7.33	10.47	0.63
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	33.89	8.87	14.55	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	31.46	5.51	12.58	3.54
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	28.57	20.05	8.91	0.52
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	37.99	19.19	9.25	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	29.02	14.56	6.61	0.67
esophagus, adult, pool1	10015-101C6	18.26	7.22	4.14	0.21
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	69.01	8.77	15.65	3.76
eye - muscle inferior rectus, donor1	10272-104E2	31.39	12.07	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	29.46	4.21	6.31	0.00
eye - muscle medial, donor2	10299-104H2	8.93	1.49	7.44	0.00
eye - muscle superior, donor2	10297-104G9	32.10	1.15	4.59	0.00
eye - vitreous humor, donor1	10268-104D7	33.52	7.29	2.91	0.00
eye, fetal, donor1	10054-101G9	17.29	6.36	9.41	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	30.26	7.95	4.62	0.64
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	40.12	12.11	9.97	1.42
frontal lobe, adult, pool1	10040-101F4	55.64	14.82	10.51	1.41
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	43.24	13.81	13.81	2.40
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	29.90	13.90	4.94	0.37
gall bladder, adult	10198-103E9	12.55	3.86	11.35	0.24
gamma delta positive T cells, donor1	11937-126A2	50.46	10.74	8.05	0.00
gamma delta positive T cells, donor2	11938-126A3	40.34	6.35	3.36	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	38.44	9.72	7.60	0.63
gastric adenocarcinoma cell line:MKN45	10612-108F9	16.83	5.03	2.90	0.00
gastric cancer cell line:AZ521	10549-107H9	63.12	13.61	7.05	0.98
gastric cancer cell line:GSS	10560-108A2	58.57	17.39	2.75	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	36.10	8.45	4.34	1.60
giant cell carcinoma cell line:LU65	10487-107B1	49.91	10.90	5.74	1.26
giant cell carcinoma cell line:Lu99B	10433-106E1	54.44	11.20	10.08	0.70
glassy cell carcinoma cell line:HOKUG	10688-109F4	24.19	11.72	6.98	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	31.35	9.82	10.45	2.53
glioblastoma cell line:A172, tech_rep2	10444-106F3	30.33	8.01	10.11	1.54
glioblastoma cell line:T98G	10485-107A8	43.38	13.24	3.86	0.77
glioma cell line:GI-1	10413-106B8	34.27	6.15	3.81	0.88
globus pallidus - adult, donor10196	10175-103C4	48.11	14.58	11.66	0.00
globus pallidus, adult, donor10252	10161-103A8	38.57	23.92	9.52	0.24
globus pallidus, adult, donor10258	10367-105F7	28.75	6.85	4.11	0.00
globus pallidus, newborn, donor10223	10364-105F4	37.30	8.53	6.40	5.33
granulocyte macrophage progenitor, donor1	12131-128D7	12.24	0.00	19.58	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	21.86	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	31.36	0.00	15.68	0.00
granulosa cell tumor cell line:KGN	10624-108H3	16.96	4.48	3.20	0.64
hIPS +CCl2, biol_rep1	14383-156B9	40.40	4.13	3.67	2.30
hIPS +CCl2, biol_rep2	14384-156C1	46.18	4.57	2.29	0.91
hIPS +CCl2, biol_rep3	14385-156C2	43.15	2.58	2.58	0.64
hIPS, biol_rep1	14380-156B6	68.99	2.87	2.87	5.75
hIPS, biol_rep2	14381-156B7	37.72	2.74	2.74	2.74
hIPS, biol_rep3	14382-156B8	51.86	9.93	6.62	1.10
hairy cell leukemia cell line:Mo	10712-109I1	30.17	8.62	2.59	0.86
heart - mitral valve, adult	10205-103F7	14.65	6.88	7.18	0.60
heart - pulmonic valve, adult	10206-103F8	16.21	9.41	8.63	0.26
heart - tricuspid valve, adult	10207-103F9	21.65	9.16	13.32	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	14.49	5.10	4.90	0.61
heart, adult, diseased, donor1	10051-101G6	7.66	2.13	4.68	0.43
heart, adult, pool1	10016-101C7	21.16	12.19	4.83	0.00
heart, fetal, pool1	10046-101G1	35.53	9.45	6.26	0.51
hepatic mesenchymal tumor cell line:LI90	10778-110G4	16.97	3.39	4.94	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	23.78	2.38	21.41	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	37.79	9.06	5.97	1.33
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	42.72	9.95	6.68	1.58
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	41.43	10.21	5.76	2.43
hepatoma cell line:Li-7	10484-107A7	64.84	11.90	5.34	0.78
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	67.23	12.06	5.13	4.02
hippocampus - adult, donor10196	10169-103B7	46.37	11.36	7.57	0.95
hippocampus, adult, donor10252	10153-102I9	34.49	17.14	7.14	0.41
hippocampus, adult, donor10258	10374-105G5	55.77	9.96	3.49	1.99
hippocampus, newborn, donor10223	10363-105F3	23.62	7.75	7.75	1.41
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	31.13	3.66	5.49	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	18.26	5.89	2.36	1.77
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	22.60	2.79	2.54	1.02
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	20.86	2.82	6.77	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	16.53	2.84	6.20	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	19.74	4.93	6.45	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	23.36	3.80	6.13	1.17
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	24.56	2.37	5.82	1.51
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	28.36	3.34	7.92	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	32.91	3.32	7.58	0.95
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	24.59	3.70	5.95	0.64
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	35.01	6.06	6.06	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	22.22	3.29	2.82	1.56
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	14.25	1.47	1.97	2.46
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	37.53	6.11	2.62	2.62
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	21.76	2.10	6.49	0.95
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	22.24	2.62	4.80	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	25.49	3.50	4.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	20.35	2.26	3.77	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	21.83	0.45	2.27	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	23.18	2.19	3.45	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	23.35	2.61	5.88	1.80
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	24.97	2.90	6.10	2.32
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	18.83	2.39	4.18	1.20
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	19.77	2.22	5.17	1.11
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	22.54	3.42	4.28	1.43
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	26.54	5.72	3.27	4.08
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	19.01	1.76	6.69	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	21.54	2.85	2.85	0.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	15.13	1.51	4.24	0.61
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	25.34	3.62	5.69	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	21.92	1.33	8.63	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	21.04	4.36	7.44	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	22.50	3.32	7.16	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	36.35	4.54	7.57	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	28.23	3.70	4.37	2.69
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	23.67	4.11	4.35	0.97
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	27.63	2.67	4.01	1.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	22.93	3.90	7.80	1.95
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	23.84	1.53	3.36	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	120.37	0.00	9.76	6.51
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	23.17	3.64	6.62	1.32
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	30.65	2.19	1.64	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	26.06	3.98	4.34	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	22.78	3.56	2.85	0.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	29.83	2.39	2.39	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	40.76	4.06	5.96	1.63
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	16.43	1.35	5.93	0.81
immature langerhans cells, donor1	11904-125F5	31.96	7.99	1.94	5.33
immature langerhans cells, donor2	11905-125F6	23.76	7.13	10.30	4.75
insula, adult, pool1	10039-101F3	48.93	11.92	8.71	0.76
keratoacanthoma cell line:HKA-1	10791-110H8	18.53	4.88	7.48	0.33
kidney, adult, pool1	10017-101C8	23.53	9.01	10.11	0.50
kidney, fetal, pool1	10045-101F9	21.36	4.95	7.57	0.28
large cell lung carcinoma cell line:IA-LM	10509-107D5	53.26	10.94	16.33	0.99
large cell lung carcinoma cell line:NCI-H460	10839-111E2	13.41	2.76	3.46	0.41
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	15.78	4.04	4.40	0.00
left atrium, adult, donor1	10079-102A7	17.44	4.90	3.27	0.00
left ventricle, adult, donor1	10078-102A6	16.18	9.10	2.02	0.00
leiomyoblastoma cell line:G-402	10721-110A1	26.27	7.93	6.02	0.82
leiomyoma cell line:10964C	10569-108B2	12.57	5.75	2.16	0.36
leiomyoma cell line:15242A	10570-108B3	17.39	7.61	2.17	0.54
leiomyoma cell line:15425	10571-108B4	17.97	9.23	3.16	0.97
leiomyosarcoma cell line:Hs 5.T	10722-110A2	12.70	6.35	12.70	6.35
lens epithelial cell line:SRA 01/04	10647-109A8	14.64	9.41	6.27	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	45.22	7.32	4.25	1.42
liposarcoma cell line:KMLS-1	10782-110G8	16.40	4.84	6.87	0.31
liposarcoma cell line:SW 872	10726-110A6	24.61	4.75	14.62	0.24
liver, adult, pool1	10018-101C9	15.07	7.94	10.86	0.49
liver, fetal, pool1	10086-102B5	8.47	1.88	2.82	0.00
locus coeruleus - adult, donor10196	10182-103D2	29.75	9.33	10.06	0.58
locus coeruleus, adult, donor10252	10165-103B3	24.91	10.15	5.91	0.37
locus coeruleus, adult, donor10258	10375-105G6	23.98	3.39	7.05	0.56
locus coeruleus, newborn, donor10223	10362-105F2	42.06	12.62	6.73	4.21
lung adenocarcinoma cell line:A549	10499-107C4	27.82	10.93	2.91	0.42
lung adenocarcinoma cell line:PC-14	10408-106B3	27.58	15.17	10.34	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	15.69	5.80	3.03	0.13
lung, adult, pool1	10019-101D1	14.53	6.97	5.43	0.24
lung, fetal, donor1	10068-101I5	77.35	9.99	14.27	3.42
lung, right lower lobe, adult, donor1	10075-102A3	17.41	5.50	10.54	0.46
lymph node, adult, donor1	10077-102A5	20.83	5.68	5.68	0.47
lymphangiectasia cell line:DS-1	10727-110A7	22.36	6.36	7.23	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	35.62	11.02	11.17	1.21
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	50.97	7.65	1.70	1.70
mature adipocyte, donor1	12231-129F8	18.20	10.66	19.98	1.78
mature adipocyte, donor2	12232-129F9	18.47	9.75	7.89	1.25
mature adipocyte, donor3	12233-129G1	29.87	13.75	15.41	0.47
mature adipocyte, donor4	12234-129G2	25.01	11.84	8.95	1.32
maxillary sinus tumor cell line:HSQ-89	10414-106B9	40.50	20.49	8.10	0.48
medial frontal gyrus - adult, donor10196	10170-103B8	72.19	13.54	13.54	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	44.69	14.90	6.80	0.74
medial frontal gyrus, adult, donor10258	10368-105F8	46.38	14.30	3.49	0.64
medial frontal gyrus, newborn, donor10223	10352-105E1	76.77	14.07	6.82	7.25
medial temporal gyrus - adult, donor10196	10183-103D3	65.31	18.06	8.61	1.35
medial temporal gyrus, adult, donor10252	10156-103A3	51.15	16.77	6.15	0.85
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	121.35	5.78	1.93	5.78
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	157.89	0.00	0.00	14.35
medial temporal gyrus, newborn, donor10223	10353-105E2	39.12	12.20	7.18	3.95
medulla oblongata - adult, donor10196	10174-103C3	31.15	11.68	9.09	1.95
medulla oblongata, adult, donor10252	10155-103A2	31.43	13.31	9.75	1.39
medulla oblongata, adult, pool1	10038-101F2	26.37	8.08	7.75	0.65
medulla oblongata, newborn, donor10223	10361-105F1	20.14	7.64	5.21	2.08
medulloblastoma cell line:D283 Med	10838-111E1	40.30	8.19	6.42	1.33
medulloblastoma cell line:ONS-76	10759-110E3	23.23	6.24	6.60	0.12
melanoma cell line:COLO 679	10514-107E1	44.56	9.63	8.62	1.87
melanoma cell line:G-361	10465-106H6	62.44	15.20	6.79	1.36
meningioma cell line:HKBMM	10691-109F7	12.48	3.44	1.09	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	36.13	8.81	12.34	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	42.25	9.07	7.26	1.04
mesenchymal precursor cell - adipose, donor1	11747-123G1	26.08	8.75	4.30	0.61
mesenchymal precursor cell - adipose, donor2	11748-123G2	33.99	4.36	5.27	0.73
mesenchymal precursor cell - adipose, donor3	11749-123G3	26.92	8.28	4.56	2.48
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	21.07	5.20	2.25	0.56
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	25.61	7.32	4.43	1.16
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	27.07	10.41	6.25	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	27.98	9.44	8.07	1.20
mesenchymal precursor cell - cardiac, donor2	11753-123G7	19.21	4.26	2.88	0.69
mesenchymal precursor cell - cardiac, donor3	11754-123G8	22.55	4.38	4.51	1.06
mesenchymal precursor cell - cardiac, donor4	11755-123G9	24.17	7.83	7.16	1.49
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	30.30	8.25	5.98	2.85
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	25.03	7.58	7.90	2.31
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	21.72	4.01	5.12	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	23.39	4.54	2.79	0.70
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	19.60	5.51	2.86	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	23.36	4.31	3.95	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	14.79	3.10	2.90	0.31
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	17.33	5.02	5.24	1.37
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	48.25	8.39	2.94	4.20
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	23.61	5.08	1.20	0.45
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	18.91	5.60	5.60	1.05
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	25.40	5.15	4.42	1.10
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	18.89	4.86	4.01	1.43
mesenchymal stem cell line:Hu5/E18	10568-108B1	24.00	7.58	7.58	0.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	19.64	5.94	7.76	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	18.93	10.23	7.16	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	25.91	7.59	7.07	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	21.57	6.16	5.85	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	19.77	7.06	2.82	0.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	19.97	7.45	6.09	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	21.22	7.86	4.72	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	17.61	7.88	6.49	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	48.30	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	27.11	6.92	8.94	2.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	18.74	8.03	5.80	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	22.35	10.34	6.97	0.96
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	19.80	3.67	5.13	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	12.42	7.72	6.38	1.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	21.29	5.73	6.55	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	24.48	4.30	5.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	27.34	10.94	10.94	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	5.16	5.16	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	25.98	9.74	6.17	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	36.37	8.73	4.36	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	22.92	4.80	8.00	1.07
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	14.72	5.72	4.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	15.94	6.22	7.00	0.78
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	23.09	6.30	6.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	22.85	5.96	5.96	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	42.90	4.77	0.00	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	20.75	5.34	3.56	1.19
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	24.37	7.31	7.31	3.66
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	25.34	6.33	8.23	1.90
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	21.04	7.24	6.55	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	27.94	0.00	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	19.96	3.99	19.96	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	20.66	6.89	10.33	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	18.74	5.30	4.07	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	14.30	3.18	4.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	17.10	6.48	2.95	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	23.38	4.99	2.18	0.94
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	20.05	6.68	8.02	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	22.47	3.55	10.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	28.25	0.00	5.14	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	16.52	7.57	8.95	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	13.36	4.95	6.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	7.85	4.49	5.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	14.63	5.09	7.00	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	11.28	7.25	10.48	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	17.44	4.36	8.72	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	11.40	5.07	3.80	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	34.59	10.32	10.92	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	31.63	22.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	11.53	9.06	9.88	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	19.45	9.13	8.53	0.99
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	15.25	5.19	4.87	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	21.39	8.15	11.20	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	17.80	2.32	6.19	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	41.34	13.23	5.43	1.89
mesothelioma cell line:ACC-MESO-4	10494-107B8	42.63	6.49	13.21	18.53
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	42.74	12.82	17.09	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	41.00	8.94	5.45	4.21
mesothelioma cell line:Mero-25	10850-111F4	37.45	5.22	2.04	4.77
mesothelioma cell line:Mero-41	10851-111F5	50.12	12.71	9.05	5.62
mesothelioma cell line:Mero-48a	10852-111F6	31.66	10.85	4.21	2.21
mesothelioma cell line:Mero-82	10853-111F7	44.15	6.83	6.57	2.63
mesothelioma cell line:Mero-83	10854-111F8	26.55	5.96	4.26	1.19
mesothelioma cell line:Mero-84	10855-111F9	14.66	4.30	5.06	5.56
mesothelioma cell line:Mero-95	10856-111G1	38.92	6.83	8.28	6.21
mesothelioma cell line:NCI-H2052	10847-111F1	38.10	9.94	4.31	0.99
mesothelioma cell line:NCI-H226	10846-111E9	40.54	10.32	6.52	3.44
mesothelioma cell line:NCI-H2452	10848-111F2	41.85	17.08	13.67	5.64
mesothelioma cell line:NCI-H28	10845-111E8	27.48	9.92	4.33	0.25
mesothelioma cell line:No36	10857-111G2	30.01	7.18	7.18	4.57
mesothelioma cell line:ONE58	10858-111G3	43.89	8.13	8.40	5.96
migratory langerhans cells, donor1	11901-125F2	45.68	9.79	1.73	0.19
migratory langerhans cells, donor2	11902-125F3	39.57	13.07	1.47	0.24
migratory langerhans cells, donor3	11903-125F4	55.10	12.92	0.90	1.08
mixed mullerian tumor cell line:HTMMT	10689-109F5	35.26	5.55	4.24	2.29
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	24.58	4.24	0.85	0.64
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	32.02	10.60	6.91	0.69
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	16.94	7.80	2.09	0.95
myelodysplastic syndrome cell line:SKM-1	10772-110F7	44.35	11.46	5.91	0.74
myeloma cell line:PCM6	10474-106I6	47.84	14.03	1.98	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	16.23	5.07	4.57	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	31.97	7.65	6.08	0.78
nasal epithelial cells, donor1, tech_rep1	12226-129F3	26.74	8.80	6.57	0.56
nasal epithelial cells, donor1, tech_rep2	12226-129F3	33.90	11.03	5.15	0.15
nasal epithelial cells, donor2	12227-129F4	44.16	13.80	6.62	0.55
neuroblastoma cell line:CHP-134	10508-107D4	48.77	4.83	7.13	0.23
neuroblastoma cell line:NB-1	10539-107G8	42.84	9.35	11.79	0.75
neuroblastoma cell line:NBsusSR	10607-108F4	55.67	5.06	4.85	5.06
neuroblastoma cell line:NH-12	10555-107I6	51.25	6.15	9.69	0.75
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	34.63	5.22	8.78	0.95
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	34.21	8.08	12.67	0.95
neuroectodermal tumor cell line:TASK1	10774-110F9	34.82	3.62	18.31	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	31.79	7.63	16.53	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	15.97	4.79	5.32	0.27
neutrophil PMN, donor1	12133-128D9	0.00	0.00	14.87	0.00
neutrophil PMN, donor2	12137-128E4	13.28	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	18.94	18.94	18.94	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	88.28	12.35	18.27	1.52
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	21.61	9.61	3.20	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	12.50	2.56	7.05	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	23.65	6.04	6.83	1.05
nucleus accumbens, adult, pool1	10037-101F1	44.53	11.34	9.56	0.37
occipital cortex - adult, donor10196	10172-103C1	183.37	49.45	18.54	2.06
occipital cortex, adult, donor10252	10163-103B1	38.38	17.18	7.78	0.27
occipital cortex, newborn, donor10223	10355-105E4	46.95	12.01	6.19	1.09
occipital lobe, adult, donor1	10076-102A4	29.65	12.86	5.77	1.05
occipital lobe, fetal, donor1	10073-102A1	54.50	9.44	4.72	2.15
occipital pole, adult, pool1	10036-101E9	22.71	6.86	4.65	0.32
olfactory region, adult	10195-103E6	26.75	8.02	6.50	0.96
optic nerve, donor1	10277-104E7	36.02	2.00	14.01	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	35.65	15.15	5.13	0.34
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	75.56	12.23	5.22	1.65
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	42.33	15.92	12.19	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	24.49	6.01	4.85	0.46
osteoclastoma cell line:Hs 706.T	10704-109H2	17.93	5.00	5.00	0.88
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	29.90	5.61	9.34	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	21.63	4.67	5.94	2.12
ovary, adult, pool1	10020-101D2	22.10	3.58	6.38	0.52
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	25.48	5.13	3.85	0.55
pancreas, adult, donor1	10049-101G4	20.69	7.53	3.76	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	26.84	10.06	5.31	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	55.88	11.58	13.80	4.09
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	27.16	6.29	5.96	0.50
paracentral gyrus, adult, pool1	10035-101E8	40.64	10.43	6.86	0.37
parietal cortex, adult, donor10258	10373-105G4	52.11	13.21	5.87	2.94
parietal lobe - adult, donor10196	10171-103B9	31.04	13.17	9.40	0.00
parietal lobe, adult, donor10252	10157-103A4	48.46	13.11	7.41	0.29
parietal lobe, adult, pool1	10034-101E7	33.75	9.87	8.20	0.44
parietal lobe, fetal, donor1	10072-101I9	60.13	8.73	4.85	0.00
parietal lobe, newborn, donor10223	10356-105E5	52.34	10.47	4.86	2.99
parotid gland, adult	10199-103F1	14.80	5.55	6.17	0.00
penis, adult	10200-103F2	23.10	7.52	12.35	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	53.18	8.18	9.30	0.37
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	23.46	5.54	11.22	1.17
pineal gland - adult, donor10196	10179-103C8	35.48	10.32	8.39	1.29
pineal gland, adult, donor10252	10160-103A7	58.04	19.54	11.84	0.00
pineal gland, adult, donor10258	10377-105G8	35.74	11.91	9.41	0.63
pituitary gland - adult, donor10196	10180-103C9	45.53	9.11	17.20	0.00
pituitary gland, adult, donor10252	10162-103A9	83.91	18.24	16.16	0.52
pituitary gland, adult, donor10258	10378-105G9	43.41	4.26	21.28	0.00
placenta, adult, pool1	10021-101D3	25.48	8.49	6.99	0.43
plasma cell leukemia cell line:ARH-77	10840-111E3	30.59	8.61	5.30	0.66
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	16.96	7.32	2.65	0.31
pons, adult, pool1	10033-101E6	35.29	10.24	8.69	0.77
postcentral gyrus, adult, pool1	10032-101E5	28.86	6.71	6.89	0.52
promyelocytes/myelocytes PMC, donor1	12132-128D8	4.18	0.00	23.01	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	16.52	16.52	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	11.74	23.47	0.00
prostate cancer cell line:DU145	10490-107B4	26.95	10.05	5.24	0.73
prostate cancer cell line:PC-3	10439-106E7	48.82	16.34	7.08	0.36
prostate, adult, pool1	10022-101D4	19.50	6.53	7.71	0.63
putamen, adult, donor10196	10176-103C5	29.98	10.39	14.87	0.00
putamen, adult, donor10252	10152-102I8	25.49	9.80	5.88	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	69.94	7.65	3.28	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	31.89	10.39	6.77	0.24
putamen, newborn, donor10223	10365-105F5	94.46	25.49	6.00	15.74
rectal cancer cell line:TT1TKB	10469-106I1	18.33	9.31	5.53	3.49
rectum, fetal, donor1	10067-101I4	22.26	9.74	12.52	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	25.44	12.08	3.60	0.85
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	38.52	13.25	5.80	0.83
retina, adult, pool1	10030-101E3	26.74	6.36	16.30	0.50
retinoblastoma cell line:Y79	10475-106I7	56.90	8.05	9.09	1.82
rhabdomyosarcoma cell line:KYM-1	10787-110H4	23.11	3.20	5.66	1.11
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	57.36	6.75	12.65	1.41
sacrococcigeal teratoma cell line:HTST	10695-109G2	15.16	0.76	4.55	0.00
salivary acinar cells, donor1	11771-123I7	23.47	8.25	7.61	0.81
salivary acinar cells, donor2	11772-123I8	19.28	10.05	9.09	0.41
salivary acinar cells, donor3	11773-123I9	11.92	5.30	16.55	0.00
salivary gland, adult, pool1	10093-102C3	20.02	4.00	12.58	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	111.71	25.04	15.51	3.54
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	98.51	25.27	16.57	2.82
seminal vesicle, adult	10201-103F3	21.16	9.52	11.11	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	17.25	7.04	8.75	1.46
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	17.36	6.04	7.05	2.26
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	37.13	7.02	4.01	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	24.18	3.49	8.19	2.15
signet ring carcinoma cell line:Kato III	10436-106E4	31.17	6.63	3.65	0.77
signet ring carcinoma cell line:NUGC-4	10483-107A6	53.80	25.68	12.77	0.90
skeletal muscle - soleus muscle, donor1	10282-104F3	14.19	4.26	2.13	0.00
skeletal muscle, adult, pool1	10023-101D5	22.91	6.12	5.16	0.36
skeletal muscle, fetal, donor1	10066-101I3	15.08	2.01	3.02	1.01
skin, adult, donor1	10074-102A2	20.36	13.57	6.79	0.00
skin, fetal, donor1	10065-101I2	26.51	8.84	10.73	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	28.68	8.34	4.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	48.54	5.36	7.25	3.78
small cell lung carcinoma cell line:DMS 144	10841-111E4	35.85	8.10	5.78	0.77
small cell lung carcinoma cell line:LK-2	10541-107H1	37.25	11.04	6.59	0.99
small cell lung carcinoma cell line:NCI-H82	10842-111E5	24.93	4.83	5.63	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	55.57	11.55	7.85	1.53
small intestine, adult, pool1	10024-101D6	25.68	10.63	12.30	1.43
small intestine, fetal, donor1	10064-101I1	26.29	8.11	7.86	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	14.87	8.72	1.03	0.00
smooth muscle, adult, pool1	10048-101G3	16.54	7.75	7.50	0.26
somatostatinoma cell line:QGP-1	10781-110G7	18.76	6.43	4.29	0.27
spinal cord - adult, donor10196	10181-103D1	36.02	8.26	10.55	0.23
spinal cord, adult, donor10252	10159-103A6	35.09	14.98	4.73	0.00
spinal cord, adult, donor10258	10369-105F9	30.44	6.92	2.77	0.69
spinal cord, fetal, donor1	10056-101H2	23.78	10.37	10.37	0.61
spinal cord, newborn, donor10223	10359-105E8	33.06	7.35	6.89	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	17.77	4.33	7.62	0.75
spleen, adult, pool1	10025-101D7	23.24	5.51	7.16	0.11
spleen, fetal, pool1	10044-101F8	25.11	4.37	7.55	0.32
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	40.89	16.25	6.83	0.72
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	28.48	8.16	4.94	0.57
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	24.81	11.18	5.24	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	30.10	7.04	4.30	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	42.55	11.14	10.58	0.34
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	47.02	17.37	3.81	0.85
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	34.69	11.85	4.65	2.96
stomach, fetal, donor1	10062-101H8	26.70	13.88	16.02	0.00
submaxillary gland, adult	10202-103F4	18.23	11.96	15.38	0.00
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	22.02	10.80	4.78	1.04
substantia nigra, adult, donor10258	10371-105G2	46.55	6.72	0.00	1.03
substantia nigra, newborn, donor10223	10358-105E7	28.26	10.60	6.36	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	39.66	14.44	6.88	1.38
temporal lobe, adult, pool1	10031-101E4	20.68	6.27	5.09	0.17
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	39.89	9.26	6.41	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	44.39	6.15	3.96	3.08
tenocyte, donor1	11763-123H8	21.64	6.63	5.24	1.75
tenocyte, donor2	11765-123I1	15.26	4.20	8.39	0.76
tenocyte, donor3	11768-123I4	21.50	5.56	4.82	1.11
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	53.88	7.31	5.61	2.55
teratocarcinoma cell line:NCR-G1	10798-110I6	30.21	5.24	6.63	0.92
teratocarcinoma cell line:PA-1	10807-111A6	23.09	2.01	6.20	0.46
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	27.55	4.19	4.57	2.16
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	62.78	10.21	6.05	2.65
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	39.92	8.51	4.47	1.74
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	41.04	8.14	4.23	1.30
testis, adult, pool1	10026-101D8	50.57	6.55	15.35	1.29
testis, adult, pool2	10096-102C6	46.91	6.77	28.87	4.06
thalamus - adult, donor10196	10168-103B6	77.28	23.18	12.14	0.00
thalamus, adult, donor10252	10154-103A1	30.48	18.29	7.97	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	113.93	10.78	6.16	4.62
thalamus, adult, donor10258, tech_rep2	10370-105G1	16.96	7.08	6.26	0.33
thalamus, newborn, donor10223	10366-105F6	35.67	9.21	4.03	4.60
throat, adult	10209-103G2	21.47	6.74	9.49	0.75
throat, fetal, donor1	10061-101H7	27.42	4.27	14.63	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	40.54	8.55	7.15	0.60
thymus, adult, pool1	10027-101D9	30.02	6.96	7.56	0.20
thymus, fetal, pool1	10043-101F7	44.99	9.77	9.77	1.25
thyroid carcinoma cell line:KHM-5M	10776-110G2	27.66	11.04	6.65	0.80
thyroid carcinoma cell line:TCO-1	10783-110G9	36.60	8.52	16.20	0.28
thyroid, adult, pool1	10028-101E1	19.22	6.35	14.65	0.00
thyroid, fetal, donor1	10060-101H6	18.72	5.27	18.98	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	18.48	12.32	12.32	0.00
tongue, adult	10203-103F5	23.26	6.74	5.12	0.00
tongue, fetal, donor1	10059-101H5	25.62	8.28	4.73	0.00
tonsil, adult, pool1	10047-101G2	30.35	8.82	8.72	0.20
trachea, adult, pool1	10029-101E2	22.00	6.38	9.82	0.57
trachea, fetal, donor1	10058-101H4	29.62	8.08	11.16	1.15
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	22.32	8.50	4.96	0.71
transitional-cell carcinoma cell line:5637	10418-106C4	52.08	10.33	9.73	1.52
transitional-cell carcinoma cell line:JMSU1	10492-107B6	46.07	12.85	8.62	0.63
tridermal teratoma cell line:HGRT	10694-109G1	9.51	0.00	15.22	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	19.55	5.42	10.07	0.34
umbilical cord, fetal, donor1	10057-101H3	10.43	0.00	4.17	2.09
uterus, adult, pool1	10100-102D1	37.71	6.14	9.04	0.51
uterus, fetal, donor1	10055-101H1	32.25	8.19	8.19	0.51
vagina, adult	10204-103F6	18.09	9.05	6.46	0.00
vein, adult	10191-103E2	17.76	5.70	9.43	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	20.56	2.67	2.67	1.07

Property "Nearest transcripts" (as page type) with input value "ENST00000531757.5:225 ENST00000418116.6:235 ENST00000534213.5:245 ENST00000534641.5:245 ENST00000265963.9:245 NM_005316.4:245 NM_001142307.2:245 AK299621:245 AK127204:245 ENST00000526461.1:246 ENST00000525831.5:247 AK299730:247 ENST00000532227.1:260 BC000365:274 BC004452:274 GQ891448:274 AK312974:285 M95809:380" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.